The QualityStocks Daily Tuesday, April 23rd, 2024

Today's Top 3 Investment Newsletters

QualityStocks(CZOO) $9.0200 +80.76%

Broad Street(PEGY) $0.0566 +23.58%

SmallCapRelations(FRES) $0.4700 +20.82%

The QualityStocks Daily Stock List

Cazoo Group (CZOO)

MarketBeat, QualityStocks, Timothy Sykes, The Online Investor, Schaeffer's, MarketClub Analysis and Investors Underground reported earlier on Cazoo Group (CZOO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cazoo Group Ltd (NYSE: CZOO) (FRA: 8QE0) is an online car retail firm that provides a platform which allows consumers to purchase used vehicles online.

The firm has its headquarters in London, the United Kingdom and was incorporated in 2018 by Alexander Edward Chesterman. Prior to its name change, the firm was known as Capri Listco. The firm mainly serves consumers in the United Kingdom and Europe.

The company is focused on transforming the car purchasing experience across Europe and the UK. Its objective is to make the experience of purchasing a car easy, transparent and convenient. It does so by allowing consumers to seamlessly finance, purchase or subscribe to a vehicle entirely online for either collection or delivery, in 72 hours.

The enterprise offers a range of hatchbacks and sport utility vehicles, which include different hybrid and electric vehicles. Its portfolio of cars includes Fiat, Skoda, Volkswagen, Nissan, Mercedes-Benz, Land Rover, Ford, BMW and Audi. The enterprise also provides car care services, including paint and fabric protection and extended warranty. Its Paint and Fabric protection includes paintwork fading and protection from pollution, among others. Its extended warranty offers cover for electrical and mechanical parts, including clutch and air conditioning, automatic and manual gearbox, diesel particulate filter, engine, cooling system, steering, suspension and braking system.

The company is focused on its continued growth and expansion in Europe and the UK. It plans to capitalize on opportunities that allow them to deliver the best car selling and purchasing experience for consumers, which will be good for its revenues as well as its investments.

Cazoo Group (CZOO), closed Tuesday's trading session at $9.02, up 80.7615%, on 23,623,880 volume. The average volume for the last 3 months is 148,237 and the stock's 52-week low/high is $2.11/$207.00.

Galectin Therapeutics (GALT)

RedChip, MarketBeat, MarketClub Analysis, StockMarketWatch, StreetInsider, BUYINS.NET, QualityStocks, Marketbeat.com, TradersPro, TraderPower, The Street, Schaeffer's, Streetwise Reports, SmarTrend Newsletters, Hit and Run Candle Sticks, InvestmentHouse, BullRally, TopPennyStockMovers, CoolPennyStocks, Daily Trade Alert, FeedBlitz, HotOTC, Investing Futures, Investors Insights, MadPennyStocks, The Online Investor, SeriousTraders, PennyInvest, StockOodles, PennyStockVille, Profit Confidential, Street Insider, AllPennyStocks, StockRich, Wallstreetlivechat, SmallCap Network, Stock Alerts, Stock Gumshoe, StockEgg, StockPicksNYC and StreetAuthority Daily reported earlier on Galectin Therapeutics (GALT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Galectin Therapeutics Inc. (NASDAQ: GALT) (FRA: PHPN) is a clinical stage biopharmaceutical firm that is focused on drug research and development of new treatments for severe skin ailments, fibrotic diseases, various cancers and other select ailments.

The firm has its headquarters in Norcross, Georgia and was incorporated in 2000, on July 10 by Anatole A. Klyosov and James C. Czirr. Prior to its name change in May 2011, the firm was known as Pro-Pharmaceuticals Inc.

The firm is involved in researching and developing small organic molecule inhibitors of galectin-3 for oral administration, through Galectin Sciences LLC, a collaborative joint venture which is co-owned by SBH Sciences Inc. It uses its carbohydrate technology to target important mediators of pathologic and biologic functions known as galectin proteins.

The company’s product candidates include a galactoarabino-rhamnogalacturonan polysaccharide polymer known as GR-MD-02 (belapectin), which is currently undergoing phase 3 clinical trials to test for its effectiveness in treating cancers as well as liver fibrosis that is associated with non-alcoholic steatohepatitis cirrhosis and fatty liver disease. Additionally, it also develops GE-MD-02 for treating psoriasis and GM-CT-01, which is currently in pre-clinical development and has been indicated for the treatment of vascular and cardiac fibrosis.

The firm recently released data from its ongoing phase 1 trial for belapectin showing reduced monocytic myeloid-derived suppressor cells and fewer immune-mediated adverse events. The candidate may, in the near future, be approved as a treatment for melanoma, lung cancer and head and neck cancer, which will not only boost the firm’s stocks but also make it popular among investors.

Galectin Therapeutics (GALT), closed Tuesday's trading session at $3.38, up 10.4575%, on 235,682 volume. The average volume for the last 3 months is 10.455M and the stock's 52-week low/high is $1.28/$4.2684.

Enzolytics Inc. (ENZC)

QualityStocks, MarketClub Analysis and Trades Of The Day reported earlier on Enzolytics Inc. (ENZC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Enzolytics Inc. (OTC: ENZC) is a biotechnology firm that is engaged in the development and commercialization of drugs based on proprietary proteins for the treatment of various debilitating infectious ailments such as HIV/AIDS.

Enzolytics Inc. has its headquarters in Bohemia, New York and serves the medical sector in the United States. The firm was incorporated on July 28, 2004.

Enzolytics Inc. also offers coating solutions in the United States, through its subsidiary. The firm works on commercializing the license rights of the IPF for the treatment of Hepatitis C and AIDS.

Enzolytics Inc. has developed an anti-HIV treatment, which it has patented, as well as a proprietary methodology for producing human IgG1 monoclonal antibodies that treat infectious ailments with non-toxic passive immunotherapy. The firm has clinically tested anti-HIV therapies and has also developed a cell line which gives rise to human monoclonal antibodies that target and neutralize the HIV virus. In addition to this, Enzolytics Inc. also provides anti-microbial protected surface coatings that hinder growth of microorganisms, mildew and mold as well as protection coatings that prevent barnacles from attaching to the hulls of marine vessels. The firm also provides construction coatings that can be used in various applications, including an epoxy spray for welding projects, blasting and coating guard rails, mold remediation, epoxy concrete floors, anti-slip and blast system for fire restoration.

Enzolytics Inc. announced in December 2020 that it had merged with BioClonetics Immunotherapeutics, which has the technology required to produce fully human monoclonal antibodies against various infectious ailments. This move will enable the firm to extend its reach while continuing with its production on a large scale, which will help the firm’s value to grow, allowing for the creation of shareholder value.

Enzolytics Inc. (ENZC), closed Tuesday's trading session at $0.00418, up 44.1379%, on 25,394,586 volume. The average volume for the last 3 months is 858,614 and the stock's 52-week low/high is $0.0016/$0.132.

American BriVision Corporation (ABVC)

MarketBeat, QualityStocks, MarketClub Analysis, AllPennyStocks, Prism MarketView, Profitable Trader Authority, Prism Market View, PennyStockScholar, PennyStockProphet, OTCtipReporter and FreeRealTime reported earlier on American BriVision Corporation (ABVC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

American BriVision (Holding) Corporation is a clinical stage biopharmaceutical company listed on the OTCQB. It is developing therapeutic solutions in oncology/hematology, CNS, as well as ophthalmology. The Company has an active pipeline of six drugs and one medical device (ABV-1701/Vitargus®) under development. Founded in 2015, American BriVision has its corporate office in Fremont, California.

The Company centers on using its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process at world-famous research institutions. These include Stanford University, University of California at San Francisco, and Cedars-Sinai Medical Center. American BriVision then focuses on out-licensing the products to global pharmaceutical companies for pivotal Phase III studies and, eventually, generating worldwide sales.

American BriVision has its medical device, Vitargus®. In addition, it has its medicine ABV-1505, which is designed to alleviate attention-deficit hyperactivity disorder (ADHD).

Vitargus® is the world’s first biodegradable vitreous substitute used during vitrectomy surgery. The Company states that Vitargus® offers important advantages over present vitreous substitutes by minimizing medical complications and lessening the need for additional surgeries.

American BriVision Corporation (ABVC), closed Tuesday's trading session at $1.35, up 29.8077%, on 8,641,601 volume. The average volume for the last 3 months is 11,541 and the stock's 52-week low/high is $0.6739/$9.60.

Protagenic Therapeutics (PTIX)

MarketBeat, QualityStocks, StreetInsider, SmarTrend Newsletters, The Street, The Online Investor, Wall Street Resources, InvestorPlace and Investing Futures reported earlier on Protagenic Therapeutics (PTIX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Protagenic Therapeutics Inc. (NASDAQ: PTIX) (FRA: MBPC) is a biopharmaceutical firm that is focused on discovering and developing therapies for the treatment of stress-related neuropsychiatric and mood disorders.

The firm has its headquarters in New York, the United States and was incorporated in 1994, on February 3rd by Hartoun Hartounian, David A. Lovejoy and Garo H. Armen. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers in the United States.

The company has a team of biotech industry veterans and researchers focused on realizing the potential of nature’s more highly-conserved neuropeptides. It develops new and naturally occurring human brain hormones for the treatment of mood disorders, which include anxiety, depression, post-traumatic stress disorder, and alcohol and drug addiction.

The enterprise’s pipeline is comprised of a synthetic form of TCAP (Teneurin Carboxy-terminal Associated Peptide) dubbed PT00114, which is an endogenous brain signaling peptide that has been designed to diminish overactive stress responses. This formulation has also shown pre-clinical effectiveness in an opioid withdrawal murine model known as the Saleens test. The enterprise has also developed a portfolio of new neuropeptides that are in different stages of pre-clinical evaluation and development for the treatment of mood disorders.

The company recently announced its latest financial results, with its CEO noting that they were making progress towards moving the PT00114 formulation into the clinic. This will not only benefit patients with stress-related neuropsychiatric disorders but also help create value for its shareholders.

Protagenic Therapeutics (PTIX), closed Tuesday's trading session at $1.57, up 25.6%, on 71,418 volume. The average volume for the last 3 months is 5.582M and the stock's 52-week low/high is $0.6797/$2.32.

WiSA Technologies (WISA)

QualityStocks, AwesomeStocks, StockMarketWatch, StreetInsider, MarketBeat, Small Caps, MarketClub Analysis, PennyStockLocks, BUYINS.NET, Penny Stock 101, PennyStockProphet, Profitable Trader Authority, StockEarnings, StockRockandRoll, PennyStockScholar, The Stock Dork, 360 Wall Street, OTCtipReporter, Money Wealth Matters, Schaeffer's, Jeff Bishop, HotOTC, Buzz Stocks, StockOnion, Awareness Stocks and Penny Pick Finders reported earlier on WiSA Technologies (WISA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

WiSA Technologies Inc. (NASDAQ: WISA) (FRA: SUE1) is focused on the development, manufacture and sale of audio wireless technology for next-generation home entertainment systems and smart devices.

The firm has its headquarters in Beaverton, Oregon and was incorporated in 2010, on July 23rd. Prior to its name change in March 2022, the firm was known as Summit Wireless Technologies Inc. It operates as part of the semiconductors industry, under the technology sector. The firm serves consumers around the globe.

The company is the founder of the Wireless Speaker and Audio Association and works in joint partnership with other parties. It works with CE manufacturers and brands to deliver dynamic and seamless audio experiences for HD content, including gaming/e-sports, sports, music, videos and movies among others. The company has a branch in San Jose, California and has sales teams in Korea, Japan, China and Taiwan.

The enterprise’s products include the WiSA Home Theater Technology and the WiSA Discrete System Technology. The home theater technology receives and transmits uncompressed 24-bit 96kHz sound over a wireless network it creates. The enterprise’s home theater products include the Home Theater RX DAC Board, the Home Theater USB TX, the Home Theater TX Dev Kit and the Home Theater TX. On the other hand, the discrete system technology received and transmits audios wirelessly. It works by transmitting up to 5 channels of uncompressed sixteen-bit 48 kHz sound over a 2.4 GHz network it creates.

The firm remains focused on creating an ecosystem with embedded WiSA-enabled products, which will help extend its consumer reach while also bringing in additional investments and revenues.

WiSA Technologies (WISA), closed Tuesday's trading session at $5.39, up 24.7685%, on 8,906,306 volume. The average volume for the last 3 months is 320,380 and the stock's 52-week low/high is $1.6601/$402.00.

ChromaDex Corp. (CDXC)

RedChip, QualityStocks, SmallCap Network, MarketBeat, Wall Street Resources, TraderPower, BUYINS.NET, StockMarketWatch, SmallCapVoice, FeedBlitz, MarketClub Analysis, Greenbackers, Stock Rocket Report, Michael Stone, Growing Stocks Reports, StockOodles, StockRockandRoll, InvestorPlace, PennyStockLocks.com, TradersPro, Marketbeat.com, ResearchOTC, FreeRealTime, Investor Update, DreamTeamNetwork, Daily Stock Motion, OTC Markets Group, Penny Pick Insider, Penny Stocks VIP, Real Pennies, Red Chip, Research Driven Investor, SECFilings.com News, Stock News Now, Stock Traders Chat, The Stock Dork, Trades Of The Day and PennyStocks24 reported earlier on ChromaDex Corp. (CDXC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

ChromaDex Corp. (NASDAQ: CDXC) (FRA: OCD1) is an integrated nutraceutical firm that is engaged in the acquisition, development and commercialization of various ingredient technologies.

The firm has its headquarters in Los Angeles, California and was incorporated in 1999 by Frank L. Jaksch Jr. and Mark S. Germain. It serves consumers in the United States. The firm’s subsidiaries include Spherix Consulting Inc., ChromaDex Analytics Inc. and ChromaDex Inc.

The company operates through the Analytical reference standards and services, Ingredients and Consumer products segments. The analytical segment is involved in the supply of phytochemical reference standards and other R&D services while the ingredients segment is involved in the supply of ingredients as raw materials to consumer product manufacturers. On the other hand, the products segment is engaged in the provision of finished dietary supplement products which contain the company’s proprietary ingredients, directly to distributors and consumers.

The enterprise conducts research on NAD+ (nicotinamide adenine dinucleotide) and commercializes it as the flagship NIAGEN ingredient. NIAGEN is an active ingredient used in the enterprise’s consumer products under the Tru Niagen name. It also provides a Braun-type lipoprotein dubbed Immulina, which has been designed to support human immune function. Immulina includes active compounds and spirulina extracts. In addition to this, the enterprise provides reference standards and services that can be used to carry out quality control of consumer products and raw materials in pharmaceutical industries, life sciences, food and beverages, cosmetics and dietary supplements.

The company recently announced its latest financial results, which show strong growth delivery and that the company achieved record sales. Its CEO noted that the company was now focused on its long-term goals, noting that its prospects looked stronger than ever.

ChromaDex Corp. (CDXC), closed Tuesday's trading session at $3.4, up 15.2542%, on 461,357 volume. The average volume for the last 3 months is 517,383 and the stock's 52-week low/high is $1.25/$4.65.

Bit Origin (BTOG)

StockWireNews, StockStreetWire, Small Cap Firm, QualityStocks and Fierce Analyst reported earlier on Bit Origin (BTOG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bit Origin Limited (NASDAQ: BTOG) (FRA: C1U) is an emerging growth firm that is engaged in the crypto mining business.

The firm has its headquarters in Chongqing, the People’s Republic of China and was incorporated in 2018, on January 23rd. Prior to its name change in April 2022, the firm was known as China Xiangtai Food Co. Ltd. It operates as part of the blockchain industry, under the financial sector. The firm serves consumers in China, Canada and the United States.

The company is now focused on the development of blockchain technologies. It operates vertically integrated, clean energy-based mining sites pipelines in progress in Latin America, Africa and North America with a total capacity of about 1GW. It was formerly involved in the retail and wholesale of feed raw material and mainly served animal husbandry businesses, feed solution manufacturers and trading firms.

The enterprise is now actively deploying blockchain technologies alongside its diversified strategies for expansion. It is also involved in the development of cloud mining platform design and manufacturing of mining machines. This is in addition to being involved in the incubation and acquisition of mining facilities. Furthermore, the enterprise is also engaged in the provision of diversified expansion strategies.

The company, which is focused on expanding its footprint in the U.S., recently gave an update of its operations, which showed increases in its revenues and Bitcoins mined. It remains committed to achieving its objective of becoming a leading Bitcoin mining firm, which will drive investments and revenues into the company.

Bit Origin (BTOG), closed Tuesday's trading session at $2.66, up 12.2363%, on 163,235 volume. The average volume for the last 3 months is 116,390 and the stock's 52-week low/high is $1.25/$9.71.

Cato Corp (CATO)

The Online Investor, InvestorPlace, Zacks, MarketBeat, SmarTrend Newsletters, Marketbeat.com, Market Intelligence Center Alert, The Street, Barchart, Daily Trade Alert, StreetAuthority Daily, BUYINS.NET, StreetInsider, TopStockAnalysts, Trades Of The Day, ProfitableTrading, Investment U, Dividend Opportunities, Investors Alley, Money Morning, Schaeffer's, Stockhouse, StockMarketWatch and MarketTamer reported earlier on Cato Corp (CATO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Cato Corp. (NYSE: CATO) (FRA: CO2A) is a specialty retailer of fashion apparel and accessories.

Cato Corp. has its headquarters in Charlotte, North Carolina and was incorporated in 1946. It operates as part of the apparel retail industry, under the consumer cyclical sector. The firm primarily serves consumers in the United States.

The enterprise operates through a pair of segments; the operation of fashion specialty stores segment (Retail Segment) and a credit card segment (Credit Segment). Its merchandise lines include coats, dresses, shoes, lingerie, dressy, career, and casual sportswear, costume jewelry, handbags, men's wear and lines for kids and infants. The enterprise’s apparel specialty stores operate under the names Cato Fashions, Cato, Cato Plus, Its Fashion Metro, Its Fashion, and Versona, including e-commerce websites. The Versona brand stores and e-commerce website offer quality fashion apparel items, jewelry and accessories at value rates every day. The enterprise provides its own credit cards to its customers and all credit authorizations, payment processing and collection efforts are performed by a wholly-owned subsidiary of the company. It operates approximately 1,178 fashion specialty stores in 31 states, principally in the southeastern United States.

The company recently announced its latest financial results, noting that the primary driver of its revenues was the retail segment which contributed over US$705 million of total revenue. It remains focused on investing in key capital projects and efficiency initiatives that support the company’s long-term growth. This may positively influence investments into the company while also opening up new avenues to generate value for its shareholders.

Cato Corp (CATO), closed Tuesday's trading session at $5.01, off by 1.7647%, on 92,164 volume. The average volume for the last 3 months is 29.66M and the stock's 52-week low/high is $4.715/$8.91.

Tilray Brands Inc. (TLRY)

Schaeffer's, InvestorPlace, StocksEarning, StockEarnings, The Street, QualityStocks, MarketClub Analysis, MarketBeat, Trades Of The Day, Daily Trade Alert, StockMarketWatch, Kiplinger Today, StreetInsider, The Online Investor, Wealth Insider Alert, Market Intelligence Center Alert, BUYINS.NET, Zacks, Investopedia, CFN Media Group, CNBC Breaking News, Early Bird, Daily Profit, The Street Report, INO Market Report, StreetAuthority Daily, FreeRealTime, Inside Trading, Trading For Keeps, Tip.us, Trading Concepts, Prism MarketView, InvestmentHouse, Top Pros' Top Picks, The Rich Investor, Investors Alley, Eagle Financial Publications, InsiderTrades, InvestorsObserver Team, Investment House, Rick Saddler, wyatt research newsletter, Wealth Daily, VectorVest, TradersPledge, TheTradingReport, The Night Owl, Money Morning, Stock Up Featured, InvestorsUnderground, Outsider Club, AllPennyStocks, MarketClub, Marketbeat.com, Louis Navellier, Jim Cramer, Jason Bond and StrategicTechInvestor reported earlier on Tilray Brands Inc. (TLRY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

California authorities recently conducted a comprehensive operation aimed at dismantling illegal marijuana operations across the state, seizing more than $53 million worth of illicit cannabis between Jan. 1, 2024, and March 31, 2024. The crackdown spearheaded by the state’s governor’s office targeted search warrants in various counties, including eight in Orange, one in San Joaquin, two in Riverside, one in Los Angeles, two in Alameda, five in Kern and one in Fresno.

During the operation, law enforcement confiscated $53,620,600 worth of illegal marijuana along with 31,866 pounds of unlicensed product and 11 firearms. Additionally, approximately 54,137 unlicensed marijuana plants were eradicated during the multicounty effort.

Governor Gavin Newsom stressed the significance of combating illegal marijuana activities, noting that it not only undermined the regulated market but also posed risks to public health and the environment. He highlighted the state’s commitment to fostering a legal market while aggressively tackling illicit operations associated with human trafficking as well as organized crime.

Established in 2022 by Governor Newsom, the Unified Cannabis Enforcement Taskforce (UCETF) plays a pivotal role in coordinating enforcement efforts among federal, state and local agencies. Led by the state’s Fish & Wildlife Department (CDFW) and the Cannabis Control Department (DCC), with support from the Homeland Security Division of the Governor’s Office of Emergency Services (Cal OES), the task force comprises more than two dozen partners working collaboratively to disrupt illegal marijuana activities.

The Alcoholic Beverage Control, Cannabis Control, Employment Development, Fish & Wildlife, and Tax & Fee Administration departments, the California National Guard Counter Drug Task Force, the California Division of Occupational Safety & Health, and the California State Parks were among the state agencies and departments that took part in this year’s Q1 UCETF operations.

Since the task force’s establishment, 236 search warrants have been carried out, yielding the confiscation of illicit marijuana valued at $371,199,431. In addition, during enforcement actions, 139 guns and more than 401,458 illegal cannabis plants have been seized so far.

Nathaniel Arnold, CDFW’s acting chief, highlighted UCETF’s dedication to prioritizing high-impact targets and leveraging resources from partner agencies to enhance public safety, protect the environment and support the regulated marijuana market. In parallel efforts, California recently allocated $12 million in cannabis grants to 10 cities and counties statewide, aimed at supporting equity programs for communities disproportionately affected by past drug policies. The funds support programs that help applicants secure startup financing, comply with regulations and receive technical support.

The broader cannabis industry, including leading companies such as Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY), will be hoping that all jurisdictions where marijuana is legal take firm action against the marijuana black market because it not only threatens the viability of the regulated market but also poses serious public health risks.

Tilray Brands Inc. (TLRY), closed Tuesday's trading session at $1.84, up 6.9767%, on 25,194,421 volume. The average volume for the last 3 months is 1.635M and the stock's 52-week low/high is $1.50/$3.40.

atai Life Sciences N.V. (ATAI)

QualityStocks, MarketBeat, The Online Investor, StockMarketWatch, Dynamic Wealth Report, StreetInsider, MarketClub Analysis, Small Caps, Uncommon Wisdom, Marketbeat.com, CRWEWallStreet, PsychedelicNewsWire, CRWEPicks, InsiderTrades, CRWEFinance, BestOtc, DrStockPick, PennyOmega, PennyToBuck, Schaeffer's, StockHotTips, TraderPower, Awareness Stocks, StockOodles, Street Insider, The Street, TopPennyStockMovers, Broad Street and ProTrader reported earlier on atai Life Sciences N.V. (ATAI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

New research has looked into the influence of psychedelic substances on sexual functioning and satisfaction. This comes as scientists learn more about the promising potential of psychedelics in treating mental-health conditions.

Various studies have looked into the effectiveness of psilocybin in alleviating symptoms of anxiety. Psilocybin, the primary psychedelic compound found in different species of hallucinogenic mushrooms, has also shown comparable effectiveness to escitalopram in reducing symptoms of depression in patients with major depressive disorder. Escitalopram is a selective serotonin reuptake inhibitor (SSRI) antidepressant. SSRIs have different side effects, a common one being sexual dysfunction. Sexual dysfunction may lower an individual’s libido, make it hard for them to get aroused, and delay or prevent them from achieving orgasm during sex.

This was the basis of the recent study, which examined the effect of psychedelics on sexual function.

For their study, the investigators assessed psychedelic use in naturalistic ceremonies and settings to better understand the effect it had on different aspects of sexual functioning. Here, they collected data from persons who had attended a ceremony involving the consumption of psychedelics such as psilocybin, LSD and ayahuasca. Once this was done, they conducted a six-week clinical trial that compared the effectiveness of psilocybin therapy in treating major depressive disorder, with that of escitalopram.

During this period, the investigators examined the domains of sexual satisfaction, arousal, pleasure, sexual desires and body image, as well as sexual functioning. They were focused on understanding whether psychedelics influenced sexual desires and openness to sexual exploration using self-constructed questions. They also assessed the differences in this association among female and male patients with major depressive disorder.

From their naturalistic study, the investigators determined that psychedelic use caused improvements in some domains of sexual functioning and satisfaction, including partner satisfaction and body image. They also observed improvements in pleasure and communication during sex. Results from their trial supported these findings, with the investigators noting that the effects of psilocybin therapy with regard to sexual functioning were positive. When compared with psilocybin therapy, escitalopram therapy was found to have a negative effect on sexual functioning.

In their report, the investigators explained that the difference in the impacts of psilocybin and escitalopram therapy on sexual functioning could be linked to the mechanisms by which they relieve depression. SSRIs work by inhibiting reintake of serotonin, increasing concentration of serotonin and promoting the chemical’s activity in the postsynaptic phase.

Overall, the study’s findings showed that psilocybin therapy as a treatment for major depressive disorder could positively affect an individual’s sexual functioning. The study’s findings were reported in the “Scientific Reports” journal.

This study widens the possibilities for the therapeutic use of psilocybin, adding to the medical conditions that entities such as atai Life Sciences N.V. (NASDAQ: ATAI) are focusing on conducting psychedelic clinical studies for.

atai Life Sciences N.V. (ATAI), closed Tuesday's trading session at $1.97, up 5.3476%, on 1,200,332 volume. The average volume for the last 3 months is 11.637M and the stock's 52-week low/high is $1.025/$2.85.

Canopy Growth Corp. (CGC)

InvestorPlace, Schaeffer's, The Street, MarketClub Analysis, Trades Of The Day, MarketBeat, StocksEarning, Daily Trade Alert, Kiplinger Today, StockEarnings, The Online Investor, QualityStocks, Wealth Insider Alert, Streetwise Reports, StreetInsider, CFN Media Group, Market Intelligence Center Alert, Investopedia, Zacks, StreetAuthority Daily, Stock Up Featured, The Wealth Report, Daily Profit, Top Pros' Top Picks, SmallCapVoice, Lebed.biz, SeriousTraders, StockMarketWatch, Wall Street Grand, Profit Trends, Early Bird, Money Morning, INO Market Report, Inside Trading, Jim Cramer, CNBC Breaking News, Cannabis Financial Network News, Louis Navellier, BUYINS.NET, StocksToBuyNow, Outsider Club, Trading For Keeps, MarketClub, AllPennyStocks, Beat The Street, Wealth Daily, Cabot Wealth, VectorVest, Trading Concepts, TradersPro, TheTradingReport, Profit Confidential, Stock Gumshoe, Insider Wealth Advice, Investment U, InvestmentHouse, Rick Saddler, Raging Bull All Access, Investors Alley, 24/7 Trader, Money and Markets and Technology Profits Daily reported earlier on Canopy Growth Corp. (CGC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Home Office recently made changes to its licensing framework for the industrial hemp industry. The United Kingdom was one of the first countries to permit industrial hemp cultivation in 1993. Despite this, strict rules have long impeded farmers’ ability to meet the growing demand for hemp from different industries.

The new amendments highlight a change in the government’s stance on the burgeoning hemp industry, with industry insiders noting that the government listened to concerns on regulation.

In a recent press release, the country’s farming minister, Mark Spencer, stated that industrial hemp had great potential to unlock new revenue streams in the United Kingdom, bring extensive environmental benefits and expand the country’s bioeconomy. Spencer added that the recent changes recognized industrial hemp as an agricultural crop, which could allow more farmers to include hemp in their crop rotations and sell their harvest to the construction and textile industries.

These changes were developed in collaboration with experienced cultivators and shall take effect in the 2025 growing season. They focus on where hemp can be planted and grown, with license holders now being able to cultivate the crop anywhere on a licensed farm. This will enable farmers to plan their rotations more effectively, helping manage pests as well as soil health.

Another change allows hemp growers to apply for licenses with a future start date. This will enable growers to make future plans easily. The maximum license durations have also been extended to six years from the previous three years.

Currently, hemp cultivation is controlled by the licensing regime under the Home Office. The regime allows the production of seed and fiber from industrial hemp. The regulations note that there has to be a defined commercial end use for hemp seeds. Furthermore, the Advisory Council has been requested by the UK government to offer advice on whether THC content in varieties of industrial hemp could be increased to 0.3%. All seeds produced currently must be obtained from permitted strains with a less than 0.2% THC content.

The British Hemp Alliance applauded the changes to the licensing framework, noting that they were a game changer for hemp cultivators. With these changes, farmers’ confidence to grow the crop may improve, and processors shall have the assurance to get into long-term supply contracts.

The latest data shows that the number of hemp licenses issued in the United Kingdom in the last 10 years have increased to 136 from 6.

Many cannabis companies such as Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED) could take an interest in the regulatory changes taking place in the UK because opportunities to sell hemp-based medicinal products could open up in the near future.

Canopy Growth Corp. (CGC), closed Tuesday's trading session at $9.03, up 15.0318%, on 12,023,542 volume. The average volume for the last 3 months is 44,945 and the stock's 52-week low/high is $2.755/$19.20.

The QualityStocks Company Corner

Nutriband Inc. (NASDAQ: NTRB)

The QualityStocks Daily Newsletter would like to spotlightFathom Nutriband Inc. (NASDAQ: NTRB) .

Nutriband (NASDAQ: NTRB, NTRBW) today announced that following its engagement by Fit For Life Group ("FFL"), a major brand license holder, on April 19, 2024, the companies fully executed an exclusive supplier agreement for FFL's new product launch under one of its top brands. According to the announcement, Nutriband's wholly owned contract manufacturing subsidiary, Active Intelligence, will act as manufacturer. Founded in 2016, FFL has become a market leader for fitness equipment and yoga accessories. FFL has amassed an impressive portfolio of brands with a commitment to creating innovative products for everyone, from beginners to pros. FFL's distribution and retail partners include larger national retailers such as Amazon, Target, Walmart and Dick's Sporting Goods.

To view the full press release, visit https://ibn.fm/DplTb

Nutriband Inc. (NASDAQ: NTRB) is engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s AVERSA™ technology can be incorporated into any transdermal patch and includes aversive agents to prevent abuse, diversion, misuse and accidental exposure to drugs with abuse potential, specifically opioids.

AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to patients who need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, Canada, Mexico and Australia.

The company’s business model is to apply its transdermal technology to existing FDA-approved drugs with a goal of improving safety, efficacy and patient comfort while qualifying for a limited-development regulatory pathway that reduces the number of clinical trials required for approval of new drugs.

Nutriband has three subsidiaries, including 4P Therapeutics, its clinical and regulatory subsidiary; Pocono Pharmaceutical, a contract manufacturer for a wide range of clients; and Active Intelligence, a developer of sports recovery products. This ownership of manufacturing and clinical development capabilities drastically reduces costs for AVERSA and other technologies.

In April 2024, Nutriband announced that the company had been engaged by and received a first order from Fit For Life Group, a major brand license holder. A fully executed supplier agreement is expected to follow. Nutriband’s wholly owned Active Intelligence subsidiary will act as manufacturer.

The company is headquartered in Orlando, Florida.

Products

Nutriband’s lead product candidate is AVERSA Fentanyl, an abuse-deterrent fentanyl transdermal patch. The company announced in March 2024 that it will submit a New Drug Application to the U.S. Food and Drug Administration seeking approval to market AVERSA Fentanyl.

Nutriband has partnered with Kindeva Drug Delivery, a leading global contract development and manufacturing organization, to incorporate Nutriband’s AVERSA abuse-deterrent transdermal technology into Kindeva’s FDA-approved transdermal fentanyl patch system. Because Nutriband’s abuse-deterrent technology is incorporated into the fentanyl patch but is physically separate from and does not come in contact with the drug layer, the clinical trials typically needed to demonstrate safety and efficacy for a new drug formulation would not be required.

AVERSA Fentanyl has the potential to be the first and only abuse deterrent patch approved anywhere in the world. The company plans to seek an expedited review by the FDA, as has been granted for certain abuse-deterrent oral opioid products, which shortens the regulatory review period to six months from the conventional 10-month FDA review cycle for NDAs.

Nutriband’s AVERSA product development pipeline also includes abuse deterrent versions of currently approved and marketed transdermal patches containing buprenorphine, an opioid used to treat opioid use disorder, and methylphenidate, a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD). Both are labeled with FDA-required warnings for the risk of abuse and misuse, as well as warnings against accidental exposure.

Market Opportunity

Nutriband cites a market analysis report from Boston-based Health Advances, a healthcare and life sciences consulting firm. According to the report, upon FDA approval, AVERSA Fentanyl has the potential to reach peak annual sales of $200 million in the U.S.

The company further states that, should non-abuse-deterrent transdermal fentanyl products lose FDA marketing approval, AVERSA Fentanyl would have greater pricing flexibility and would have the potential to generate more than $500 million in annual revenue.

Management Team

Gareth Sheridan is Co-Founder and CEO of Nutriband. He was Ireland’s ‘Young Entrepreneur of the Year’ in 2014 for establishing Nutriband. He has worked as a Business Mentor with 100 Minds, a social enterprise that brings together some of Ireland’s top college students and connects them with a cause to achieve large charitable goals. He received a B.Sc. in Business and Management from Dublin Institute of Technology.

Serguei Melnik is Co-Founder and President of Nutriband. He has been involved in general business consulting for companies in the U.S. financial markets and setting up legal and financial frameworks for operations of foreign companies in the U.S. He previously was the COO of Florida-based Asconi Corporation. He also was a lawyer in the Department of Foreign Affairs, JSC Bank “Inteprinzbanca,” in Chisinau, Moldova, and prior to that practiced law in Moldova. He is fluent in four languages.

Jeff Patrick, Pharm.D., is Chief Scientific Officer of Nutriband. He currently serves as Director of the Drug Development Institute at the Ohio State University Comprehensive Cancer Center. His prior roles included Global Vice President at Mallinckrodt Pharmaceuticals Inc.; and roles at Dyax, Myogen/Gilead, Actelion and Sanofi-Synthelabo Inc. He was a clinical pharmacist at the University of Tennessee Medical Center and a clinical assistant professor of pharmacy at the University of Tennessee College of Pharmacy.

Gerald Goodman is CFO of Nutriband. He is a certified public accountant with his own firm, Gerald Goodman CPA. He also practiced with Madsen & Associates, CPAs, and was a partner in the accounting firm of Wiener, Goodman & Company. He is also a director of Lifestyle Medical Network Inc., which provides management services to healthcare providers. He is a graduate of Pennsylvania State University, where he received a bachelor’s degree in accounting.

Nutriband Inc. (NASDAQ: NTRB), closed Tuesday's trading session at $3.56, up 0.564972%, on 25,718 volume. The average volume for the last 3 months is 312,919 and the stock's 52-week low/high is $1.53/$5.9274.

Recent News

FingerMotion Inc. (NASDAQ: FNGR)

The QualityStocks Daily Newsletter would like to spotlight FingerMotion Inc. (NASDAQ: FNGR) .

A Wall Street Journal report has revealed that Beijing recently directed some of China's most prolific telecom carriers to stop using computer chips sourced from foreign manufacturers. According to the report, the Chinese government has instructed major telcos such as China Telecom, China Unicorn and China Mobile to phase out foreign chips from their operations by the year 2027.

The move is the latest in an escalating trade war between the United States and China that has seen both countries take steps to deprive each other of critical raw materials, limit exports and prevent trade between American and Chinese companies. With the U.S. already instructing local chip makers to stop selling semiconductor chips to companies in China, it seems the Asian country is now retaliating by banning American chips from its telecommunications industry. State-owned enterprises, for instance, were ordered in 2022 to replace foreign office software systems with domestic offerings by 2027. The Financial Times reported last month that Beijing has also issued guidelines to guide the phase-out of Intel and AMD semiconductor chips from government personnel servers and computers. It remains to be seen how companies with a commercial interest in the telecommunications industry in China, such as FingerMotion Inc. (NASDAQ: FNGR), could be impacted by this new directive by the Chinese government.

FingerMotion Inc. (NASDAQ: FNGR) is an evolving technological company with core competencies in mobile payment and recharge platform solutions in China. FingerMotion is in the process of developing additional value-added technologies to market to users.

Founded in 2016, FingerMotion’s goal is to serve over a billion users in the Chinese market and expand its model to other regional markets. The company has offices in Hong Kong, Shanghai and New York City.

Current Offerings

FingerMotion is analyzing and transforming mobile data to improve the lifestyle of the public through technology and innovation. The company’s current offerings include:

  • Telecommunications Products and Services – FingerMotion’s proprietary universal exchange platform, ‘PigeonHole Integration System (PIS)’, offers seamless integration between telecom operators and online stores. The service platform’s offerings include top up and recharge, data plan, mobile phone, loyalty points redemption and subscription plans. The platform offers reliable and secure transactions, real-time reconciliation, simple integration for partners and efficient settlements.
  • SMS and MMS Services – The integrated platform is registered as FingerMotion’s IP in China and provides a robust back-end control panel for corporate partners to manage their own messaging settings. FingerMotion’s clients range from insurance to financial industries, ecommerce firms, airlines and more. The platform offers competitive pricing for partners and provides quick and efficient review to meet timely marketing initiatives.
  • Big Data Insights – FingerMotion brings Big Data-enabled insurance solutions through its Big Data Insights arm, Sapientus. The company’s strategic partnerships with the largest Chinese telecommunications giants allow access to uncover behavior insights through geolocation and mobile data usage. Its Big Data offerings include risk scoring, precise marketing, simplified underwriting and customized products.
  • Rich Communication Services (RCS) – FingerMotion’s RCS platform will be a proprietary business messaging solution that enables businesses and brands to communicate their services to customers via 5G infrastructure. The company expects its RCS platform to offer a better user experience, more efficiency and cost-effectiveness when compared to other solutions.

Telecommunications and Insurtech Markets

The global telecommunications market was valued at $1.74 trillion in 2019 and is expected to grow at a CAGR of 5% from 2020 to 2027. The steady increase is expected to be driven by the adoption of 5G and the increased popularity of Internet of Things (IoT) applications.

The Chinese telecom market was valued at $254.1 billion in 2017 and is also constantly expanding. The current Chinese telecom market is dominated by three mobile operators – China Mobile, China Unicom and China Telecom, which together are responsible for around 1.6 billion active subscribers (https://ibn.fm/zfwy9).

In addition, the insurtech (insurance technology) market was valued at $2.72 billion globally in 2020 and is expected to grow at a CAGR of 48.8% from 2021 to 2028. The large increase is attributed to the rising use of technology solutions for everyday activities like acquiring insurance coverage (https://ibn.fm/TGo7D).

Through its proprietary platforms and technologies, FingerMotion is uniquely positioned to capitalize on the telecom and insurtech markets’ growth and opportunities.

Management Team

Martin J. Shen is the Chief Executive Officer of FingerMotion Inc. He has over 15 years of experience in senior management roles within entrepreneurial startups and large multinational corporations. He has acquired a wide range of corporate management, financial oversight and operation administration expertise through these roles. In his most recent role, he founded Imperial Distributors (formerly known as AP Martin Pharmaceutical Supplies Ltd.), establishing the company as the preferred choice for distributional support to regional pharmacies throughout Western Canada. Before founding Imperial, Mr. Shen served as the Chief Operating Officer and Chief Financial Officer at Wales and Son Industrial (formerly Weir Minerals), a firm specializing in global delivery and support for mining slurry equipment. He began his career at PricewaterhouseCoopers in Vancouver, with work tours in the tax department in Singapore and the tax audit and advisory group in Hong Kong. Mr. Shen is a U.S. Certified Public Accountant and holds a Bachelor of Science from the University of British Columbia.

Lee Yew Hon is the company’s Chief Financial Officer. From 2006 until November 2020, he was the Chief Financial Officer of Cubinet Interactive Group of Companies, and he also took on the Chief Operating Officer role in 2011. During his tenure, he was instrumental in leading Cubinet and building teams across the Southeast Asia region, setting up financial processes within a short time. Mr. Lee spearheaded the growth of Cubinet to other regions, including Europe, the Middle East and Russia. He received his diploma from Tunku Abdul Rahman College in 1996. He is a Chartered Accountant, a member of the Malaysia Institute of Accountants (MIA) and an Associate Member of the Chartered Institute of Management Accountants, UK (ACMA).

Li Li is the Senior Vice President of FingerMotion. She recently served as Advisor to Shenzhen WuYiKa Technology Co. Ltd., a comprehensive service platform dedicated to online service distribution and payment. The company has become a fast and efficient provider of new media marketing solutions for the mobile internet. She has held high-level management positions with multiple industry names, including Hangzhou JiuYue Information Technology Co. Ltd. and Hangzhou LingXuan Information Technology. Ms. Li started her career in 2004, founding Shanghai ChuangYeZZ Network Technology Co. Ltd. and serving as its Vice President. With the close cooperation of local operators, the company launched SMS, MMS, WAP, mobile JAVA games, Hunan Satellite TV e-magazine and other wireless internet services to meet the rapid development of wireless internet and application requirements. She received her degree from Nanjing Academy of Engineering.

FingerMotion Inc. (FNGR), closed Tuesday's trading session at $3.15, up 2.6059%, on 330,869 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $5.9274/$.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has announced that its Chief Executive Officer John Climaco will present at the LSX World Congress 2024. Climaco is slated to present at 4:15 PM (GMT+1) on Monday, April 29, 2024, at the event taking place in London, England. In addition to the presentation, CNSP announced that its management will be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference. To view the full press release, visit https://ibn.fm/tx16y

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (http://nnw.fm/eDUjp).

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Tuesday's trading session at $0.21, up 5.4746%, on 147,832 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.19/$2.98.

Recent News

Diamond Lake Minerals Inc. (OTC: DLMI)

The QualityStocks Daily Newsletter would like to spotlight Diamond Lake Minerals Inc. (OTC: DLMI).

Diamond Lake Minerals (OTC: DLMI), a leading multi-strategy operating company specializing in developing and supporting digital assets and SEC-registered security tokens, was featured in an article published by Proactive. The piece discusses the recently unveiled collaboration between Diamond Lake Minerals and modular home builder BOXABL Inc. to develop communities known as BOXABL Villages. DLMI expects the partnership to streamline processes and shorten timelines to residents' possession of their BOXABL homes and believes its leadership in security tokens combined with traditional means will "create unique opportunities for these villages to thrive and scale." "DLMI and BOXABL are working together to develop not only the BOXABL Village Concept but also utilizing the large reach and influence we have created here at DLMI to provide solutions to affordable housing," DLMI CEO Brian J. Esposito was quoted as saying. "The crisis that the housing market industry is experiencing is in desperate need of a realistic, attainable fix. I truly believe that BOXABL is the first modular home company to crack the code on this, and together we intend on making quite the impact."

To view the full article, visit https://ibn.fm/vPoGz

Diamond Lake Minerals Inc. (OTC: DLMI) is a multi-strategy operating company offering traditional investors an entry point to the future of digital securities. The company’s goal, through its established M&A roadmap, is to responsibly innovate and develop promising businesses that are likely to benefit from the ongoing shift toward digital assets. Through this approach, Diamond Lake Minerals provides traditional investors an opportunity to gain exposure to the emergence of regulated digital securities through a more familiar investment vehicle – the purchase of stock.

Founded in 1954 and headquartered in Salt Lake City, Diamond Lake Minerals is positioning itself as a leader in the digital asset and security token space. The company’s mission is to bring back to the public markets timeless business principles focused on healthy, sustainable growth and strong earnings with a goal of creating value for stakeholders in the modern digital world.

Diamond Lake Minerals believes the future of financial markets is set to be revolutionized by tokenization. Tokenization refers to the use of digital assets that can be traded via protocols with instantaneous settlement and reduced fees, eliminating the need for traditional clearing or settlement processes. Beyond efficiency, the emerging landscape emphasizes transparency, liquidity and security in asset management and investment.

With the backing of Esposito Intellectual Enterprises and its 20+ years of experience, Diamond Lake Minerals has access to the expertise of 110+ companies and 200+ joint ventures, along with knowledge spanning 25+ industries. The company is creating a vertically integrated ecosystem that encompasses various high-growth sectors. This integration aims to maximize operational efficiencies and profitability across all business units.

Products & Services Portfolio

Diamond Lake Minerals, guided by its strategic partnerships and future roadmap, envisions a diverse portfolio across multiple industries, as shown in the overview below. The company is poised to redefine the conglomerate model for the 21st century, with a focus on vertical integration, digital securities and sustainable growth.

Its target market segments include:

  • Fashion: DLMI seeks stakes in brands blending timeless aesthetics with tech influences.
  • Beauty: DLMI eyes partnerships with innovators elevating beauty through sustainable practices.
  • Real Estate: DLMI aims for interests in ventures modernizing property transactions via blockchain.
  • Hospitality: DLMI’s vision includes associations with enterprises enhancing guest experiences via tech integration.
  • Liquor: DLMI aspires to collaborate with unique distillers merging tradition and innovation.
  • IoT: DLMI intends to invest in solutions seamlessly connecting the digital and physical worlds.
  • Wireless: DLMI envisions stakes in wireless tech optimizing global communication.
  • Technology: DLMI plans to back pioneers driving the next tech revolution.
  • Maritime: DLMI seeks partnerships in maritime solutions emphasizing green initiatives.
  • Aviation: DLMI’s strategy includes holdings in aviation innovators focusing on efficiency.
  • Aerospace: DLMI aims to support ventures pushing boundaries in space exploration.
  • Education: DLMI collaborates with platforms revolutionizing learning through tech.
  • Charity: DLMI eyes alliances with charitable entities leveraging transparency via blockchain.
  • Healthcare: DLMI foresees investments in healthcare tech personalizing patient care.
  • TV: DLMI intends stakes in TV platforms innovating content delivery.
  • Film: DLMI aspires to support filmmakers merging storytelling with immersive tech.
  • Music: DLMI plans interests in music ventures amplifying artists through digital platforms.
  • Entertainment: DLMI targets stakes in platforms redefining entertainment paradigms.
  • IP: DLMI envisions collaborations safeguarding intellectual properties via tech solutions.
  • Data Management: DLMI seeks ventures optimizing data utilization and insights.
  • Data Storage: DLMI’s roadmap includes alliances with secure data storage solutions.
  • Streaming: DLMI intends to back streaming platforms prioritizing user experience.
  • Real World Assets: DLMI eyes investments translating tangible assets into digital value.
  • Gold & Silver: DLMI aims for stakes in platforms digitizing precious metal trading.
  • Sports: DLMI envisions collaborations enhancing sports experiences via tech integration.
  • Sports Technology: DLMI seeks ventures revolutionizing athlete performance and fan engagement.
  • Water: DLMI plans to back solutions ensuring water sustainability and accessibility.
  • Water Treatment: DLMI targets investments in eco-friendly water purification technologies.
  • Animation: DLMI eyes stakes in animation houses blending art with cutting-edge tech.
  • Studio Production: DLMI’s vision includes support for studios transforming content creation.
  • Consumer Products: DLMI seeks partnerships with brands prioritizing consumer-centric innovations.
  • Collectables: DLMI envisions collaborations with platforms digitizing unique collectibles.
  • Digital Assets: DLMI aims to invest in ventures maximizing the potential of digital ownership.
  • Web3: DLMI aspires to back pioneers ushering in the decentralized web era.
  • Identity Management: DLMI eyes solutions prioritizing user identity security in the digital space.
  • Media & Journalists: DLMI seeks alliances promoting unbiased reporting and content democratization.
  • Metaverse: DLMI envisions stakes in ventures crafting immersive virtual universes.
  • Space Economy: DLMI targets investments in ventures monetizing space exploration.
  • Modular Homes: DLMI plans interests in solutions revolutionizing home construction.
  • Financial Technology: DLMI seeks partnerships modernizing financial transactions.
  • Gaming: DLMI aims to back game developers enhancing user immersion.
  • Travel: DLMI eyes collaborations transforming travel experiences through tech.
  • Health & Wellness: DLMI’s strategy includes investments in holistic health tech solutions.
  • Augmented Reality: DLMI envisions stakes in AR platforms blurring reality and digital.
  • AI: DLMI seeks to support AI innovations humanizing tech interactions.
  • Esports: DLMI targets investments in platforms amplifying esports experiences.
  • Construction: DLMI plans to back ventures modernizing construction practices.
  • Virtual Reality: DLMI intends stakes in VR platforms offering alternate realities.
  • Retail Tech: DLMI envisions collaborations digitizing retail experiences.
  • Biotechnology: DLMI seeks ventures pushing boundaries in biotech innovations.

Market Opportunity

According to Diamond Lake Minerals’ business plan executive summary, the market for digital securities is projected to grow from $10 billion in 2022 to $1 trillion by 2028, a CAGR of 45% for the forecast period.

The global blockchain market value is expected to grow from an estimated $3 billion in 2020 to $39.7 billion by 2025, marking a CAGR of 67.3% for the period. Valued at $2.28 billion in 2021, the Security Token Offerings market is projected to grow at a CAGR of 19%. This growth is expected to be driven by the rising adoption of tokenization and the increasing prominence of STOs, especially in North America.

In addition, the global investment management market is projected to grow from a value of $100 trillion in 2020 to $178 trillion by 2025, recording a CAGR of 7.2% over the period.

Management Team

Brian J. Esposito is CEO of Diamond Lake Minerals. As founder and CEO of Esposito Intellectual Enterprises LLC, he brings over 20 years of diverse experience in sectors like manufacturing, technology, music and real estate, and is known for his global executive networking and balance sheet optimization skills.

Michael Reynolds is President and Director of Diamond Lake Minerals. With 35 years in private finance and M&A, he has been instrumental in growing companies like Herbalife through reverse acquisition, as well as elevating JB Oxford to $120 million in revenue. His expertise in operational management and business development ensures professional solutions for clients’ business interests.

Jon Karas is DLMI’s senior transaction and investment executive. As the CEO and co-founder of Akon Legacy Ventures, he structured, negotiated and closed numerous transactions focused on innovation and social impact in smart cities, blockchain, agriculture, mining and technology. He co-founded and led multiple companies in media and entertainment and was the driving force behind the development, financing and production of a broad range of film and television content.

Advisory Board

Anthony Scaramucci, Founder and Managing Partner of SkyBridge Capital and Chairman of SALT, brings to Diamond Lake Minerals unparalleled expertise in finance, technology and business strategy. He is expected to be instrumental in shaping DLMI’s strategic direction as the company continues to redefine the future of traditional and digital securities.

Larry Namer, Founder of E! Entertainment TV and President of Metan Global, boasts a remarkable career spanning more than half a century. He is an esteemed veteran of the entertainment industry, renowned for his influential contributions to cable television, live events, music and new media. He also leads LJN Media, a consulting firm known for its cross-industry expertise in technology, business and finance.

Andrew Fromm is a seasoned CEO and consultant with a focus on music publishing. He is known for his expertise in asset sales, songwriting and artist development. His extensive network extends beyond the music industry, showcasing his versatility and authority in the field.

Brandon Fugal is the Chairman of Colliers International in Utah and a former EY Entrepreneur of the Year. He has co-founded multiple ventures, including Coldwell Banker Commercial Advisors, Cypher, Axcend and Texas Growth Fund, and he is a recognized authority in real estate and entrepreneurship.

Michael Malik Sr. is a Detroit-based entrepreneur with a $750 million net worth, known for his pivotal role in legalizing gambling and developing major casino projects across the U.S., including Detroit’s MotorCity Casino and various Native American gaming ventures. He brings to Diamond Lake Minerals a wealth of experience and a proven track record in the gaming, sporting and entertainment industries spanning over five decades.

Raul Leal is an experienced CEO in the hospitality sector, known for his visionary leadership at SH Hotels & Resorts and former role at Virgin Hotels, where he secured over $500 million in funding and revolutionized guest experiences.

Agnes Budzyn, an accomplished entrepreneur and CEO of Bluedge Ventures, brings to the company a rich history in traditional finance and blockchain technology, serving on various global boards and committees. She has been recognized by the World Economic Forum and numerous institutions for her expertise and contributions to bridging legacy finance with emerging digital asset infrastructure.

Diamond Lake Minerals Inc. (OTC: DLMI), closed Tuesday's trading session at $4.74, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.35/$5.90.

Recent News

SUIC Worldwide Holdings Ltd. (OTC: SUIC)

The QualityStocks Daily Newsletter would like to spotlightFathom SUIC Worldwide Holdings Ltd. (OTC: SUIC) .

SUIC Worldwide Holdings (OTC: SUIC), a provider of research and development, venture financing and investment for private and public companies, was featured in the latest episode of the Bell2Bell Podcast as part of IBN's sustained effort to provide specialized content distribution via widespread syndication channels. SUIC CEO Hank Wang joined the program to provide an overview of the company and its business model. "SUIC Worldwide Holdings targets opportunities to enhance and streamline existing supply chain and financial processes. SUIC is the majority and U.S. operating shareholder of Beneway Holdings Group, which is planning to file an S-1 for an IPO this year. Through its I.Hart Group subsidiary, Beneway operates 150 global chain and franchise locations of a variety of brands, and it is planning to replicate this unique brand model in the U.S.," Wang said in the interview. "Our clients include top e-commerce companies, global listing companies and global hotel chains, among others. Our products export to the U.S., Canada, the U.K., Australia, Japan, Hong Kong and countries throughout Southeast Asia."

To view the full press release, visit https://ibn.fm/goBV6

SUIC Worldwide Holdings Ltd. (OTC: SUIC) provides research and development, venture financing and investment for private and public companies that develop products and services in the areas of Internet of Things, cloud computing, mobile payments, Big Data, blockchain, artificial intelligence and global franchising. The company seeks to enhance and streamline existing processes and establish new and exciting business models that will create revolutionary products and services.

SUIC is the largest shareholder and major operating partner of Beneway Holdings Group. The I.Hart Group, a subsidiary of Beneway, currently operates 150 global chain and franchised locations under a variety of brands. It is working on integrating more successful chains to enter the U.S. chain and franchise market in all 50 states. It is replicating its successful multi-branding business model and teaming up with top U.S. real estate firms, shopping malls and associated groups to expand and achieve its target of 750 chain and franchise locations in the near future.

The company is headquartered in Flushing, New York, with offices in San Francisco, Taiwan and Malaysia.

Portfolio

SUIC works with Beneway in several business ventures, with focus on the following:

  • Fintech – Through Boom Fintech, the major subsidiary of Beneway USA, the company holds nine revolutionary fintech patents. Boom Fintech integrates payment systems, electronic invoice devices, mobile cash registers, POS system devices and ERP, as well Big Data + AI and other services, to ALL-IN-ONE products that provide standardized intellectual property that’s modular to all industries, from chain department stores to night market vendors. Beneway Holdings Group connects borrowers and lenders, building strategic partnerships by bridging the various stakeholders to provide a holistic financial delivery ecosystem and to integrate advanced systems and finance its global merchants and franchisees.
  • Food Industry Supply Chain Integration – SUIC and Beneway will partner with international trade financiers to support the huge demand for raw material import/export between the U.S. and Asia. SUIC and Beneway are looking to raise funds from an IPO and the capital markets to support mergers and acquisitions of U.S. mid- and upper-stream food industry suppliers.
  • Global Chain and Franchise Expansion – Through I.Hart catering group, SUIC and Beneway are working to bring reputable and distinguished overseas food product brands to the U.S. and around the world. It is working on integrating more successful chains to enter the U.S. chain and franchise market in all 50 states. It is replicating its successful multi-branding business model and teaming up with top U.S. real estate firms, shopping malls and associated groups for faster expansion.
  • Other Supply Chain Integration – Beneway has identified several additional industries for future expansion, including medical and health care, high-tech digital AI systems, environmental protection and energy-related production.

Market Opportunity

An analysis by Growth Market Reports, a full-service market research and business consulting organization, estimated that the value of the global Asian food market was $437.15 billion in 2022. The market value is projected to reach approximately $805.08 billion by 2031, expanding at a CAGR of 7.1% during the forecast period.

Asian cuisine is well known for its diversity, with a wide range of flavors, ingredients and cooking techniques influenced by various factors such as climate, geography, history and cultural practices. The report states that Asian food outlets are expanding at a tremendous rate in the U.S. and Europe due to rising consumer demand. Demand is driven by various factors, including the growing interest in global authentic flavors and the nutritional benefits that Asian food offers. Consumers have become increasingly exploratory with their food choices, according to the report.

McKinsey Consultants estimate that, by 2025, the global supply chain financial market will reach $20 trillion. At present, 60% of the global participants are small and medium-sized retail companies, representing the target customers of SUIC and its subsidiary. Recent Juniper Research shows that global digital commerce transaction value will also pass $20 trillion by 2027.

Management Team

Hank Wang is CEO of SUIC. Since 2018, he has served as CEO of the I.Hart Group. Prior to joining I.Hart, he was Secretary General of Taiwan Quantitative Hedging Development Association. He graduated from Tamkang University in Taiwan with a Bachelor of Finance degree.

Elena Lin is associate CFO of SUIC. She previously served as CEO of Monga Chicken. In 2015, she was recognized as one of Taiwan’s Top 100 Managers of the Year. She holds a master’s degree from the Kaohsiung University of Hospitality and Tourism’s Institute of Food Culture and Catering Innovation in Taiwan.

Elton Han is associate CTO of SUIC. He is also currently Director of Food and Beverage Development for the I.Hart Group. He also holds a position with the Taiwan International Young Chefs Association. He previously served as Executive Chef of Hanbilou, Huashan Guanzhi, Daye Group.

SUIC Worldwide Holdings Ltd. (OTC: SUIC), closed Tuesday's trading session at $1.78, even for the day, on 54 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.95/$3.00.

Recent News

Golden Triangle Ventures Inc. (OTC: GTVH)

The QualityStocks Daily Newsletter would like to spotlight Golden Triangle Ventures Inc. (GTVH).

Golden Triangle Ventures (OTC: GTVH) and its entertainment division, Lavish Entertainment, have made significant progress in transforming into reality the vision for a premier destination for year-round, world-class music, entertainment and art. "Since the announcement of Destino Ranch, a planned 638-acre property conveniently located within a short drive from large population centers such as Phoenix, Los Angeles and Las Vegas, Lavish Entertainment has officially activated the first phase of development. This phase includes the execution of a land-use-and-development agreement outlining exclusive rights to use and operate on the property. Phase one development will focus on the first nearly-70 acres of land that already has in place substantial infrastructure features, such as special-event permits, graded roads, fencing, storage, septic, solar, landscaping, and water and irrigation rights," a recent article reads. "In addition, [in March] Lavish Entertainment announced that it has executed a purchase agreement to acquire this first, nearly-70 acres of land that the company recently secured, which is primed and improved property for the Destino project. The company noted that the upgrades were valued at nearly $6 million, which ‘has turned this once-vacant land into a beautiful oasis that provides the initial infrastructure needed to begin the development of Destino Ranch.'"

To view the full article, visit https://ibn.fm/zsT3J

Golden Triangle Ventures Inc. (OTC: GTVH) is a multifaceted consulting company pursuing ventures in the health, entertainment and technology industries, with many additional projects being developed that provide synergistic values to these divisions. The company aims to purchase, acquire and/or joint venture with established entities that management can help assist and develop into unique opportunities.

Additionally, GTVH provides a professional corporate representation service to different companies in these sectors while consulting on a variety of business development objectives. The goods and services represented are driven by innovators who have passion and commitment to these marketplaces.

The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent these three sectors in which the company aims to do business.

Health Division – Global Health Services

Global Health Services is a wholly owned subsidiary of Golden Triangle Ventures (operating under its Health Division). Dedicated to the promotion of well-being and natural wellness, the company currently does business in the industrial hemp/CBD industry. Additionally, the company has a vision to promote, market and generate sales for a myriad of products and services which include a full retail line of high-end, all-natural health, wellness and beauty products.

To help achieve this vision, Global Health Services is in the process of further developing an extensive online portal that will support the multiple verticals under the company and provide a one-stop-shop for all of the company’s products and services. Moreover, to support overarching business goals, senior management tirelessly works on acquiring and building an array of profitable assets and projects.

Entertainment Division – Lavish Entertainment

Lavish Entertainment (EpicRaves) is a wholly owned subsidiary of Golden Triangle Ventures under its Entertainment Division. Operating out of Las Vegas, Nevada, the company started doing business in 2017 and was established with a vision of becoming a nationally recognized concert production company. The company currently has more than 30,000 national followers and nearly 100 team members who have helped the company successfully organize some of the most exciting Electronic Dance Music concerts in Las Vegas.

Lavish Entertainment is currently doing business as EpicRaves, which will eventually become a wholly owned subsidiary of Lavish Entertainment as the company expands its business into a variety of other forms of entertainment. The company is currently building a unique virtual reality platform to help expand on its live events, and it is working to acquire a 68,000 sq. ft. event center with a vision to develop one of the most advanced event centers in the world.

Technology Division – HyFrontier Technology

HyFrontier Technologies is a wholly owned subsidiary of Golden Triangle Ventures under its Technology Division. The company owns a patent-pending process and device technology called HyGrO, which is a molecular hydrogen and oxygen delivery system for agriculture. Golden Triangle Ventures is assisting the company in commercializing the HyGrO unit for farm and home use in markets across the globe. HyFrontier Technologies has a mission to improve global crop production efficiency by producing hydrogen and oxygen directly in the water stream.

This technology can be used on any species of plant life in nearly any grow medium. Additionally, the system can be retrofitted to wellheads for large-scale agricultural projects, indoor grow operations and small farms or utilized for a multitude of residential home and garden applications. In-house testing has shown evidence that hydrogen is capable of increasing crop yields by up to 25% and, in many circumstances, a much higher amount. Larger root systems and better overall plant health were also observed by watering plants with the HyGrO unit. Universities and multiple third-party testing facilities are currently working to validate the HyGrO technology, and all preliminary results are extremely positive.

To push the development and commercialization of the technology, management is now in the process of moving the company headquarters from Colorado to Florida, which will transition its operations into a 7,800 sq. ft. state-of-the-art manufacturing facility. The company recently executed a three-year lease with an option to purchase the entire 24,000 sq. ft. building, which will help the business in achieving its ultimate goal of commercializing this technology to the world.

Food & Wine Division – Napa Wine Brands

Napa Wine Brands is a wholly owned subsidiary of Golden Triangle Ventures which is a synergistic business with a mission of providing a world-class portfolio of unique brands birthed from Napa Valley and Sonoma Valley in the heart of California’s Wine Country.

The company has a commitment to manufacture and distribute specialty wines, foods and unique items while tapping into an array of hidden markets in the food and beverage industry. With extensive resources and award-winning products, Napa Wine Brands aims to develop some of the most desirable products in today’s market. Originated by some of the most profound experts in Napa Valley, the company’s vision is to broaden the horizon of a traditional food and wine company by creating a platform different than anything seen in the Northern Hemisphere.

Napa Wine Brands has an array of fully developed products and services that provide value to the other divisions under Golden Triangle Ventures. The company is now preparing the launch of several brands, products and services that are market-ready and will immediately turn into cash-positive businesses. Golden Triangle Ventures will provide a full support system and assist management of Napa Wine Brands in growing this company into another fun, exciting and profitable division of Golden Triangle Ventures.

Recent Updates

  • On May 26, 2021, Golden Triangle announced its acquisition of The Lodge Winery & Olive Oil Co. under the company’s Napa Wine Brands subsidiary. The Lodge Winery & Olive Oil Co. is an established wine brand that produces award-winning wines, olive oils and wine vinegars. “Our marketing team is now ready to launch an in-depth program focused on driving our products into big box stores, smaller retail outlets, online platforms and many other avenues,” Steffan Dalsgaard, CEO of Golden Triangle, stated in a news release announcing the acquisition. “We are working directly with [Napa Wine Brands CEO] Arron [Johnson] and his team to grow their bulk inventory and launch all of these products for the world to enjoy.”
  • On May 20, 2021, Golden Triangle announced its entry into a letter of intent to acquire Sonder Fulfillment LLC, a leader in the industrial hemp and CBD space that is dedicated to driving forward the most powerful and efficacious cannabinoid products in the world. “Over the past two years, our operating partners have compiled a team of the best minds in the industrial hemp industry to create a totally vertical operation from seed to shelf,” Joshua Weaver, CEO of Sonder Fulfillment, stated in a news release announcing the LOI. “This acquisition by Golden Triangle Ventures will fully capitalize our operations and allow us to further expand our product lines and enter into new markets across the globe.”
  • On May 19, 2021, Golden Triangle announced the execution of a formal agreement with Robert “Bo” DuBose to purchase the remaining 49% of HyFrontier Technologies Inc., giving Golden Triangle 100% ownership of the technology company. “This acquisition has been something that Bo and I have been working towards for quite some time and we are both incredibly happy to have this executed,” Dalsgaard stated in a news release announcing the acquisition. “We knew that completing this agreement would show the world that we are both fully committed to our shareholders and the brilliant future of this revolutionary company.”
  • On May 12, 2021, Golden Triangle announced its acquisition of a top tier, professional sound system and formed a partnership with SuperKollider Sound LLC to provide a strategic benefit to the company’s entertainment division under Lavish Entertainment Inc. “We are very excited to acquire this unbelievable sound system,” Dalsgaard stated in a news release announcing the acquisition. “Hennessey Sound Design has always been one of my favorite systems on the market, and the team at SuperKollider Sound are true professionals in this space.”

Management Team

Steffan Dalsgaard is the Founder & Executive Chairman of Golden Triangle. He has a background in business development, with over a decade of experience representing and consulting with dozens of private and public companies. Mr. Dalsgaard consults with companies on all of their corporate objectives while providing a professional and corporate face to their organizations. He has built a strong reputation in the public relations industry and has a mission to work with emerging growth companies that are positioned to become significant businesses in their respective fields.

Robert DuBose is the company’s Chief Innovations Officer & Director and the CEO of HyFrontier Technologies Inc. Mr. DuBose is responsible for the success of the HyGrO product in the agricultural market. His experience in the design and production of hydrogen equipment goes back more than a decade, including PEMFC technologies since 2009 with his company, Aquafuel Inc. Mr. DuBose was raised in the farming and machine shop business, where he learned firsthand how much work and love goes into a successful crop, as well as how elements, which are out of the farmers control, can have adverse effects on finances. His belief that being able to deliver a solution to increase growth, yield, health, stamina of crops and profitability for farmers would be a win-win for all led him to create the HyGrO product.

Stuart Seim is the Chief Development Officer & Director of Golden Triangle. He began his career as an associate professor at the University of Manitoba in the field of outdoor and environmental education after receiving his master’s degree and completing advanced educational studies. Coming from a family with an extensive financial background, Mr. Seim became a stockbroker for major regional financial firm Robert W. Baird. In a short time, he became the Branch Manager for Baird in Minneapolis, Minnesota, while also serving as a Managing Director for Baird. During this time, Mr. Seim also served on the board of an industrial hearing company, which he helped to launch as a new company (The TK Group). Mr. Seim currently resides in Colorado, where he is an advisor to several organizations.

Golden Triangle Ventures Inc. (GTVH), closed Friday's trading session at $10.83, up 4.4359%, on 81,689 volume with 697 trades. The average volume for the last 3 months is 269,609 and the stock's 52-week low/high is $2.33999991/$20.0783996.

Recent News

Correlate Energy Corp. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Energy Corp. (OTCQB: CIPI).

Transitioning from fossil fuel dependence to alternative, renewable energy sources has taken on increasing importance amid concerns about the growing consequences of climate change

Federal government incentives and experimental projects are helping to drive efforts to transition the United States to greater renewable energy use from carbon-based energy sources

Idaho-based Correlate Energy Corp. is a distributed energy solutions company making the transition to renewable energy more accessible to mid-tier companies, particularly those with nationwide portfolios that may create multiple revenue opportunities

With proven user-friendly finance models, the company works to strategically develop, and profitably sell microgrids and localized green energy solutions, with plans to ultimately retain ownership of some of its energy systems to provide sustainable revenues

Nearly 70 percent of American adults want renewable energy sources such as wind, solar and hydrogen power to be granted developmental policy priority over fossil fuels, according to a Pew Research report last year (https://ibn.fm/ZQmJD), but renewable energy development remains a politically polarizing concern (https://ibn.fm/qShmx). Success for the government initiative could be a new shot in the arm for groups pushing the adoption of renewable energy to combat the anticipated ravages of climate change. Distributed energy solutions company Correlate Energy (OTCQB: CIPI) is a company helping to promote that adoption at a corporate level for mid-tier companies that are often overlooked by large energy companies and consulting firms in the sustainability market.

Correlate Energy Corp. (OTCQB: CIPI) is a publicly-traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation.

The energy grid in the U.S. is insufficient for the booming clean energy trend, and current infrastructure is limiting green energy distribution. Constructing the needed infrastructure to address this demand imbalance will cost billions and be far too slow, positioning decentralized systems, like those on offer from Correlate, in a key position for heightened demand.

Correlate has identified several key economic drivers powering the decentralized energy trend, including:

  1. Real Cost Savings – Customer pays zero money down and gets an instant electrical price discount to current rates.
  2. Massive Project Investment Funding – The International Energy Agency estimates that over one billion dollars per day will be invested in solar energy in 2023.
  3. Consistent Long-Term Incentives – The Inflation Reduction Act is a game-changer, supercharging renewables with $1.2 trillion in tax credits for 10 years of market support.
  4. Robust Customer Demand – Wood Mackenzie expects the U.S. solar industry to nearly triple in size over the next five years.

Correlate’s team of multi-decade experts who have worked with renowned global brands are positioning the company to make the most of this opportunity while consolidating a fragmented industry. Collectively, the team has developed, financed and deployed over $2 billion in clean energy projects to date.

Three-Pronged Strategy

Correlate is leveraging a three-pronged strategy aimed at driving shareholder value:

  1. Sell – Correlate seeks to finance, develop and profitably sell localized clean energy solutions and microgrids to industrial, commercial and residential customers.
  2. Retain – Correlate plans to retain ownership of some of these energy systems and thereby realize ongoing, reliable cash flow.
  3. Acquire – Correlate seeks to acquire proven renewable energy companies in order to exponentially grow earnings per share for investors.

This strategy is enhanced by current investment trends. Clean energy earnings are being sought after by investors. In Q4 2022, the median EBITDA multiple for green energy companies was 12.3x, according to Finerva.

Market Outlook

Over the next decade and beyond, renewable energy growth is expected to come primarily via decentralized systems like those offered by Correlate.
The Inflation Reduction Act enacted in late August 2022 is likewise expected to drive growth for the company by providing new tax incentives that reduce costs for clients and/or elevate returns to investors.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings, yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which are very different from traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue, known as the ‘split incentive’, unlocking the majority of the addressable market.

A key portion of Correlate’s strategy relates to consolidation of what has been a fragmented industry. By uncovering opportunities to improve efficiencies through strategic M&A activities, the company intends to enhance profitability throughout its operations.

Management Team

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

Dave Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jed Freedlander is the company’s Chief Development Officer. He has a background in infrastructure development and investment and a strong legal, commercial and finance acumen. Mr. Freedlander has a proven track record in leading complex public-private partnership (P3) and energy transactions and is instrumental in driving Correlate’s strategic development initiatives.

Roger Baum is Executive VP Operations at Correlate. With over 20 years of experience at Core Construction, he brings to the company a wealth of knowledge and a strong track record in delivering successful commercial construction projects.

Jason Loyet is Director of Solar Energy for Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Correlate Energy Corp. (OTCQB: CIPI), closed Tuesday's trading session at $1.21, off by 13.5714%, on 1,051 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.3501/$2.35.

Recent News

PaxMedica Inc. (NASDAQ: PXMD)

The QualityStocks Daily Newsletter would like to spotlight PaxMedica Inc. (NASDAQ: PXMD).

PaxMedica (NASDAQ: PXMD), a leading biopharmaceutical company dedicated to advancing treatments for neurological disorders, expects to take immediate action in response to an urgent request for IV suramin from the Ministry of Health ("MOH") of Malawi, a country in east Africa. The request seeks emergency access to PaxMedica's recently completed registration batches of PAX-101 ("IV suramin") to address the critical shortage of medications required to combat the life-threatening sleeping sickness, also known as Trypanosoma brucei rhodesiense, Human African trypanosomiasis ("TBr HAT"), crisis in the region. "The emergency request from the Ministry of Health of Malawi underscores the critical need for IV suramin to combat the continued devastating impact of sleeping sickness in the region. PaxMedica has worked with the physicians and the government in Malawi and neighboring countries as part of the ongoing work towards a future NDA submission for PAX-101 in the treatment of TBr HAT," said Howard Weisman, chairman and CEO of PaxMedica. "Despite our current limited resources, we plan to help by providing access to PAX-101 in the next 30 days, so that these physicians can continue to use the current standard of care to treat this fatal disease. PaxMedica has worked diligently for many years to ensure access to this life-saving medication for those in need and today's response to an urgent crisis strongly demonstrates our commitment to this mission."

To view the full press release, visit https://ibn.fm/wbrws

PaxMedica Inc. (NASDAQ: PXMD) is a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (APTs) for the treatment of Autism Spectrum Disorder (ASD) and other serious conditions with intractable neurologic symptoms.

The company’s lead programs are focused on ASD, for which there are currently no approved pharmacologic treatments that target its cause and symptoms. Currently used treatments only address the symptoms of the condition, rather than targeting the pathophysiology itself.

PaxMedica is on a promising path to address these unmet medical needs, bringing hope to millions. Anti-purinergic therapies target the excess production of purines in cells. An overexpression of purines can offset homeostasis and result in an overproduction of cellular adenosine triphosphate, the main energy molecule in all living cells.

The company is headquartered in Tarrytown, New York.

Product Pipeline

PaxMedica is building a robust pipeline of products targeting ASD and related neurodevelopmental conditions. The company’s lead product in development may help eliminate, reduce or modulate some of the more troublesome aspects of ASD. That would open the potential for people with autism to integrate their behavior with others more successfully and improve their lives.

PaxMedica’s lead programs, PAX-101 and PAX-102, utilize the company’s proprietary source of suramin sodium, a broadly acting anti-purinergic therapy that has been known for over 100 years. Its current pipeline includes:

  • PAX-101 (IV Suramin) for ASD – PAX-101 completed a Phase 2B study for ASD in 2021. Suramin is a broadly acting APT and has reported positive results from a dose range study. The results of PaxMedica’s Phase 2B study, which targeted 52 subjects across six sites in South Africa, were presented to AACAP in October 2021.
  • PAX-102 (Intranasal Suramin) – PaxMedica has developed a proprietary intranasal formulation of suramin that is currently being evaluated in ASD and other neurodevelopmental conditions.
  • PAX-101 for HAT – Given suramin’s historical use as a treatment for Human African Trypanosomiasis (HAT), or African Sleeping Sickness, the company is also developing PAX-101 as a treatment for HAT. PaxMedica’s most advanced program is the pursuit of PAX-101 for early-stage East African HAT.
  • Selective APTs – PaxMedica has conducted several preclinical studies to evaluate other APTs that are more selective to specific purinergic receptors and may offer additional benefits over suramin.

Market Opportunity

According to a report by Fortune Business Insights, a leading global market research company, the global ASD therapeutics market was estimated at $1.93 billion in 2022 and is projected to grow from $2.01 billion in 2023 to $3.42 billion by 2030, a CAGR of 7.9% over the forecast period. As there is no current treatment for the core symptoms of autism, PaxMedica believes the addressable market for PAX-101, if approved, could greatly exceed these forecasts.

Autistic disorder, Asperger’s Syndrome and Pervasive Development Disorder are the three main types of ASD, affecting millions of people globally. A 2020 report by the U.S. Centers for Disease Control & Prevention estimated that one in 36 children in the U.S. have been diagnosed with autism disorder.

Several factors are expected to contribute to market growth prospects. A growing prevalence of the condition globally and rising awareness coupled with available treatment options are key factors expected to drive ASD therapeutics market growth during the forecast period. Growing investment in R&D to find effective treatments is also expected to fuel global market growth.

Management Team

Howard Weisman is Chairman and CEO of PaxMedica. He has been a founder and CEO of several specialty pharma and medical device companies. Most recently, he was executive chairman and co-founder of Sofregen, a biotech company. He also served as CEO and president of Seventh Sense Biosystems, a medical device development company. He also was founder, chairman and CEO of EKR Therapeutics, a specialty pharmaceutical company, and founder and COO of ESP Pharma, a company focused on cardio and neurovascular products. He has a bachelor’s degree in chemistry from Rutgers University.

David Hough, M.D., is Chief Medical Officer at PaxMedica. He is a neuroscience clinical development consultant who previously served as vice president at Janssen Research and Development and in various leadership roles over 17 years. Most recently, he was the compound development team leader for SPRAVATO® for treatment-resistant depression. Prior to that, he was the schizophrenia disease area leader. He played a pivotal role in the development programs for oral INVEGA®, INVEGA SUSTENNA® and XEPLION® for schizophrenia. He is a graduate of West Point and is board certified in psychiatry.

Stephen Sheldon is COO and CFO at PaxMedica. He has served as CEO of Thailand-based specialty healthcare company Indochina Healthcare Co. Ltd. since 2015. Previously, he was a consultant for PricewaterhouseCoopers Healthcare Advisory in the Chicago office. He was responsible for developing specialty pharmacy patient programs, strategy development for specialty products and compliance programs. He has an MBA from Thunderbird School of Global Management and a bachelor’s degree in computer science and visual arts from Bowdoin College.

PaxMedica Inc. (NASDAQ: PXMD), closed Tuesday's trading session at $0.716, off by 4.8252%, on 739,127 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.372/$29.75.

Recent News

Zoned Properties Inc. (OTCQB: ZDPY)

The QualityStocks Daily Newsletter would like to spotlightFathom Zoned Properties Inc. (OTCQB: ZDPY).

Zoned Properties (OTCQB: ZDPY), a leading real estate development firm for emerging and highly regulated industries including legalized cannabis, today announced that its board of directors has approved a share repurchase program, pursuant to which the company is authorized to purchase up to $1 million of its common stock over an unlimited time period. "As our business continues to outperform in a challenging overall operating environment, we are thrilled to announce this share repurchase program. The approval of this program demonstrates the management team's and board's confidence in our prospects for the future, ongoing operational strength and sound capital structure," said Bryan McLaren, chief executive officer of Zoned Properties. "As we scale the investment portfolio, we are keeping conservative in our capital allocation strategy while also acknowledging the significant valuation gap between our public valuation and tangible book value. Due to this, it is crucial for us to be adaptable and make sure we are doing everything possible to increase shareholder value. As always, we remain committed in our strategic focus, and look forward to updating shareholders on our progress."

To view the full press release, visit https://ibn.fm/Oj6AS

Zoned Properties Inc. (OTCQB: ZDPY) is a technology-driven property investment company focused on acquiring value-add real estate within the regulated cannabis industry in the United States. The company aspires to innovate within the real estate development sector, focusing on direct-to-consumer real estate that is leased to best-in-class cannabis retailers.

The company is redefining the approach to commercial real estate investment through its standardized investment process backed by its proprietary property technology. Zoned Properties has developed a national ecosystem of real estate services to support its real estate development process, including a commercial real estate brokerage and a real estate advisory practice.

With a decade of national experience and a team of experts devoted to the emerging cannabis industry, Zoned Properties is addressing the specific needs of a modern market in highly regulated industries. The company targets commercial properties that face unique zoning or development challenges, identifies solutions that can potentially have a major impact on their commercial value and then works to acquire the properties while securing long-term, absolute-net leases.

Zoned Properties targets commercial properties that can be acquired and rezoned for specific purposes, including the regulated and legalized cannabis industry. It does not grow, harvest, sell or distribute cannabis or any substances regulated under United States law.

The company is headquartered in Scottsdale, Arizona.

Portfolio

The company’s investment properties are located in Arizona, Michigan and Illinois, with 100% occupancy and a weighted average lease term over 10 years. Each of the company’s leased properties is occupied by a commercial cannabis tenant. The company is expecting rental revenue from its property investment portfolio of greater than $2.5 million in calendar-year 2024.

Zoned Properties maintains a portfolio of properties that it owns, develops and leases. As of February 2024, the company leases land and/or building space at the six properties in its portfolio to licensed and regulated cannabis tenants in areas with established cannabis regulations and zoning procedures. Four of the leased properties are zoned and permitted as regulated cannabis retail dispensaries, and two of the leased properties are zoned and permitted as regulated cannabis cultivation and processing facilities.

The company considers the two cultivation sites in its portfolio as legacy properties and may consider selling or leveraging those properties to unlock equity and create capital availability in the future. The Zoned Properties investment thesis has evolved over the years as the cannabis industry has emerged, and the company is currently focused on investing capital into direct-to-consumer properties, located in state-markets with robust cannabis consumer demand in the industry.

Zoned Properties is in pursuit of property acquisitions that can be characterized as consumer-facing, retail dispensary properties that are positioned to be leased to retail dispensary cannabis tenants under net leasing structures. As of September 2023, the company has agreements in place to acquire new investment properties with new cannabis tenants located in Arizona, Missouri and Illinois. The company plans to initiate and target its investment process in Ohio and Maryland.

With a strategic shift in focus to direct-to-consumer real estate that is leased to best-in-class cannabis retailers in the industry, the company will continue to utilize its competitive edge when identifying excellent investment properties. Zoned Properties has a full pipeline of acquisition prospects and continues to utilize an extremely disciplined capital allocation approach.

Market Opportunity

According to MJBizDaily, a publication that has covered the North American cannabis business since 2011, combined U.S. medical and recreational cannabis sales were estimated at approximately $33.6 billion at the end of 2023, largely driven by the opening of new adult-use markets.

The publication projects that combined U.S. retail cannabis sales will reach upwards of $53.5 billion by 2027, according to an analysis published in its volume of cannabis market research, the MJBiz Factbook.

As of February 2024, 38 U.S. states had legalized medical, recreational or other limited use of cannabis. The Pew Research Center reports that, in January 2023, there were more than 11,000 licensed cannabis dispensaries in the U.S. In addition, global research firm IBISWorld reports that more than 40,000 U.S. localities have adopted regulations governing cannabis usage, production, processing and/or dispensing.

Management Team

Bryan McLaren is the Chairman and CEO of Zoned Properties. Previously, he worked as a Sustainability Consultant for Waste Management Inc., where he led the strategic development and operational implementation of zero-waste programs for clients. He was also appointed as a city Sustainability Commissioner. He holds a bachelor’s degree in business administration from the University of San Diego, a master’s degree in sustainable development from Northern Arizona University, an executive master’s degree in business leadership from Arizona State and an MBA with a specialty in sustainable development.

Berekk Blackwell is the President and COO of Zoned Properties. He previously spent time in developing domestic and international markets for Kahala Brands, a conglomerate of over 15 QSR franchises, including Cold Stone Creamery and Blimpie Subs. He later worked on developing QSR concepts for Revamp Corp. in Tokyo. After returning to the U.S., he served as president of Daily Jam, a limited-service breakfast and brunch chain. He holds a bachelor’s degree in business administration in finance from Fort Lewis College.

Patrick Moroney is the Director of Real Estate Acquisitions for Zoned Properties. Previously, he was one of the most successful Associate Brokers at Kidder-Mathews, focusing primarily on the regulated cannabis industry. He also worked as a commercial real estate broker rep at Cushman & Wakefield and Colliers International. He graduated from Arizona State University, after which he spent four years as a local sports broadcaster in Georgia and Iowa.

Kyle Gere is the Director of Advisory Services at Zoned Properties. He has years of licensing experience across multiple U.S. states in the medical and recreational cannabis markets. Since 2015, he has been involved in cannabis real estate transactions in Arizona and Michigan, managing a portfolio of medical marijuana properties. He attended Northern Arizona University, graduating with a bachelor’s degree in business administration in both management and marketing.

Zoned Properties Inc. (OTCQB: ZDPY), closed Tuesday's trading session at $0.5403, off by 6.8127%, on 1,923 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.35/$0.80.

Recent News

SuperCom Ltd. (NASDAQ: SPCB)

The QualityStocks Daily Newsletter would like to spotlight SuperCom Ltd. (NASDAQ: SPCB) .

Developments in Australia's efforts to limit youth offender recidivism underscore the importance of being able to track select probationary participants

Israel-based SuperCom Ltd. is positioning itself to be a world leader in providing court-administered offender tracking, which may include youths potentially prone to recidivism

The company is growing on a global scale with contracts in Romania, Finland, Croatia, Sweden, and various states in the United States, in a marketplace with an anticipated 9.5 percent CAGR over the next five years

An Australian court's decision to have young criminal suspects wear electronic ankle bracelet monitors is helping law enforcement advocates successfully deal with concerns about violent recidivism while court proceedings are in progress, while also allowing teen suspects to enjoy a measure of freedom while under court supervision (https://ibn.fm/gWthl). Electronic-monitoring ("EM") security solutions developer SuperCom (NASDAQ: SPCB) is building clientele among government agencies worldwide to improve public safety while also limiting the stigma that teen advocates worry about in regard to wearing the monitoring bracelets.

SuperCom Ltd. (NASDAQ: SPCB) provides secured solutions for the e-government, IoT and cybersecurity sectors. Since 1988, the company has been a trusted global provider of traditional and digital identity offerings, providing cutting-edge electronic and digital security solutions to governments and organizations, both private and public, around the world.

SuperCom’s mission is to revolutionize the public safety sector worldwide through proprietary electronic monitoring technology, data intelligence, and complementary services.

The company is headquartered in Tel Aviv, Israel, with offices in California and other regions in the U.S.

Business Units

IoT and Connectivity

SuperCom IoT products and solutions provide advanced electronic monitoring solutions and services to criminal justice agencies, enabling customers to detect unauthorized movement of people, vehicles, and other monitored objects. The company provides an all-in-one, field-proven PureSecurity offender monitoring suite, accompanied by services such as GPS monitoring, home detention, domestic violence prevention, and more. The company’s services are specifically tailored to meet each client’s needs.

SuperCom’s proprietary Puresecurity suite of hardware, connectivity, and software components is the foundation for its criminal justice services and offerings. SuperCom is leveraging its extensive technology expertise to implement groundbreaking artificial intelligence (AI) technologies into various parts of its core offerings. By leveraging the power of AI, SuperCom’s PureSecurity platform can offer new abilities, such as amplified data analysis, predictive modeling, and streamlined automation – all geared toward optimizing decision-making and operational efficiency.

Competitive advantages of SuperCom’s technology include:

  • Long Battery Life (No Tag Charging Required)
  • Ultra Lightweight Form Factor
  • Next-Gen Location Tech
  • Protection of Domestic Violence Victims
  • And More

 

Cybersecurity

In 2015, SuperCom identified the cybersecurity market as a fast-growing space with significant advantages due to synergistic technologies and a shared customer base with its e-Gov and IoT business units. Consequently, SuperCom strategically acquired Prevision Ltd., a company with a strong presence in the market and a broad range of competitive cybersecurity services.

During the first quarter of 2016, SuperCom acquired Safend Ltd., an international provider of cutting-edge endpoint data protection guarding against corporate data loss and theft through content discovery and inspection, encryption methodologies, and comprehensive device and port control.

Both acquisitions significantly expanded the breadth of the company’s global cybersecurity capabilities.

e-Gov

Through proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has helped governments, and national agencies design and issue secured multi-identification, or Multi-ID, documents and robust digital identity solutions to their citizens, visitors, and lands.

The company has focused on expanding its activities in the traditional identification, or ID, and electronic identification, or e-Gov, markets, including the design, development, and marketing of identification technologies and solutions to governments in Europe, Asia, America, and Africa using SuperCom’s e-Government platforms.

Market Opportunity

Data from Berg Insight estimates the market for electronic monitoring solutions will grow from $1.2 billion in 2021 to $2.1 billion in 2026, marking a CAGR of 10.8% for the forecast period.

High recidivism rates, prison overcrowding, and soaring incarceration costs are some factors that are driving the electronic monitoring of offenders’ market growth.

An analysis by ReportLinker forecasts that the global cybersecurity market will grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, achieving a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving the cybersecurity market growth.

Management Team

Ordan Trabelsi is President and CEO of SuperCom. He has over 15 years of experience as CEO, growing high-tech companies globally. He also has experience in research and development and product innovation, as well as hands-on experience in cybersecurity, encryption, advanced mathematics, and mobile and internet network technologies. Prior to joining SuperCom, he served as co-founder and CEO of Klikot Inc., a global social networking company. He holds an MBA from Columbia University and a B.Sc. in Computer Engineering from The Technion: Israel Institute of Technology.

Barak Trabelsi is COO of SuperCom. He has expertise in big data, cyber, mobile, and internet network technologies, as well as extensive experience in product development and strategies. Prior to joining SuperCom, he served as Senior Product Manager at Equinox Ltd. Before that, he served for four years as VP of R&D at Sigma Wave, a wireless, security, and internet-focused company. He holds a B.Sc. in Computer Science and Business, as well as an MBA from Tel Aviv University.

Gil Alfi is VP of Sales at Safend Ltd., SuperCom’s cybersecurity subsidiary. He joined SuperCom in 2016 as VP of Business Development for Safend. He has more than 18 years of experience in technology companies. He served as an R&D team technology lead for more than seven years and as Director of Product Management for various telecom and wireless companies for more than 10 years. Prior to joining SuperCom, he served as Regional Sales Director at Safend, managing sales regions in Europe and Africa. He holds a B.Sc. in Computer Science and Mathematics and an M.Sc. in Computer Science from Bar-Ilan University.

SuperCom Ltd. (NASDAQ: SPCB), closed Tuesday's trading session at $0.24, off by 17.1557%, on 9,033,069 volume. The average volume for the last 3 months is 8.649M and the stock's 52-week low/high is $0.1524/$1.38.

Recent News

Freight Technologies Inc. (NASDAQ: FRGT)

The QualityStocks Daily Newsletter would like to spotlight Freight Technologies Inc. (NASDAQ: FRGT).

Freight Technologies (NASDAQ: FRGT) ("Fr8Tech") is a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning that offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region. The company today announced its preliminary financial results for Q1 2024, which concluded on March 31, 2024. Among the highlights, the company reported healthy revenue growth of 30% in Q1 2024 over the prior year with approximately $4.3 million in quarterly revenue. "The company's addition of its Fr8Fleet offering in 2022 was the right strategic response to the market dynamics of the Mexican domestic OTR freight industry," said Don Quinby, CFO of Fr8Tech. "It has proven to be a highly valued service for large enterprise customers and is a key differentiator for Fr8Tech. The company's growth trajectory continues, not just with Fr8Fleet, but also with spot and cross-border shipments. We continue to deepen relationships with existing customers, add new customers, and build carrier capacity while enhancing the capabilities and efficiency of the platform. We are excited for the year ahead."

To view the full press release, visit https://ibn.fm/q5oO8

Freight Technologies Inc. (NASDAQ: FRGT) (“Fr8Tech”) is a technology company developing solutions to optimize and automate the supply chain process, providing a platform for B2B cross-border shipping in the NAFTA region. The company’s mission is to revolutionize cross-border shipping by providing carriers with increased growth opportunities and shippers with flexibility, visibility and simplicity for the once-complex process of international over-the-road shipping.

Freight Technologies, formerly known as Hudson Capital Inc., assumed its current name and ticker symbol on May 27, 2022. Its primary operating subsidiary and its marketplace are known as Fr8App, and it conducts operations throughout North America under the names of Fr8App and/or Freight App. The company is headquartered in Houston, Texas, with multiple locations across the U.S. and Mexico.

The Fr8Tech Solutions Suite

Fr8Tech leverages artificial intelligence to provide cloud-based platforms aimed at automating the over-the-road transportation process, effectively reducing human touch points and expediting load booking times. The company’s suite of solutions includes:

  • Fr8app – A B2B marketplace powered by AI and Machine Learning offering a real-time broker portal to connect shippers with qualified carriers
  • Fr8Radar – A tracking solution providing shippers and carriers real-time locational data via Fr8app’s mobile solution or through integration with third-party GPS alternatives
  • Fr8TMS – A transportation management system designed to help shippers manage their freight and all of the documents involved in shipping transactions, including invoices, customs documents, confirmation rates and proof of deliveries
  • Fr8FMS – A fleet management system allowing transportation companies to better manage their fleets, reduce operational costs and provide better service to their customers
  • Fr8Data – A data solution offering real-time dashboards and reports to shippers and carriers in an effort to increase visibility and control while supporting better business decisions
  • Fr8Fleet – A platform that provides private fleet management, enabling large corporate shippers to purchase dedicated capacity secured by Fr8app in exchange for a fixed fee

Commitment to the Environment

Through its core focus on technology, Fr8Tech seeks to reduce the carbon footprint of the logistics industry. Its solutions aim to minimize empty miles for transportation firms and reduce overall paper consumption.

Fr8University

Fr8University is an educational program offering classroom and on-the-job training for Fr8Tech team members. Through the program, employees learn in-depth business fundamentals and applications along the truckload freight industry value chain.

Led by corporate educator Mario Mena, Fr8University is designed as an investment in the company’s human capital, providing an opportunity to communicate Fr8Tech’s corporate culture while accelerating operational growth.

Market Outlook

Fr8Tech’s established foothold in Mexico is key to its current efforts to promote sustainable growth in the cross-border shipping industry. Ongoing disruption in U.S.-Chinese trade relations have strengthened Mexico’s status as the largest trading partner of the U.S., with cross-border annual freight spending estimated at $385 billion according to data from the U.S. Department of Transportation. Annual domestic shipping in Mexico is estimated at $34 billion, while annual domestic shipping in the U.S. is estimated to total $732 billion.

Despite the size of this industry, fragmentation and inefficiencies prevail in the space. Thousands of legacy brokers, tens of thousands of shippers and hundreds of thousands of carriers still rely on outdated systems to arrange transport, spending hours on the phone negotiating pricing, waiting days to find trucks and drivers, preparing and printing forms, and operating without tracking or visibility. Add in cross-border complexity relating to customs and additional paperwork, and you have an industry ripe for technological disruption.

Fr8Tech’s recent revenue growth trends have highlighted the company’s efforts to capitalize on this opportunity. In 2021, Fr8Tech achieved revenues of $21.5 million, marking a year-over-year increase of 134%. The company issued revenue guidance for fiscal 2022 of $40 million in a February 9, 2022, press release, which would account for a further 86% year-over-year increase.

Management Team

Javier Selgas is CEO and a Director of Freight Technologies Inc. and Freight App Inc. He brings to the company over 15 years of experience developing technology and digital marketing strategies, including serving as Country Manager for Osigu, Spain, and as head of AJEgroup’s IT division for the Asia-Pacific region. Prior to joining Fr8Tech, Mr. Selgas founded digital marketing agency Lanzadera Online. He has also served as an IT consultant to major corporations, including Endesa and Ibermatica.

Mike Flinker is President of Fr8Tech. He has over four decades of experience in the transportation industry, with 30+ years focused on cross-border logistics. Prior to joining Fr8Tech, Mr. Flinker founded FLS Transportation, the largest cross-border logistics company in Canada. He also previously held positions with Clarke Transport Inc., Canadian Pacific and Reimer Express Inc. (a division of Roadway Express).

Paul Freudenthaler is the company’s CFO and Secretary to the company Board. He has over 30 years of financial expertise, having previously served as CFO for several leading companies across multiple countries, including Macquarie in Mexico, Old Mutual in Latin America and Ascentium Capital in the U.S. Mr. Freudenthaler’s experience include leadership roles from which he guided IPOs and M&A transactions.

Luisa Lopez is COO of Fr8Tech. She brings to the company 25+ years of management experience in logistics, supply chain, operations and customer service. Ms. Lopez previously served as a Director of Landstar, where she was responsible for commercial and client development strategies in the Mexican market. Additionally, she managed more than 2,000 transport units specialized in staff and school mobility while with Traxion in Mexico.

Freight Technologies Inc. (NASDAQ: FRGT), closed Tuesday's trading session at $0.9, off by 1.2291%, on 73,185 volume. The average volume for the last 3 months is 521,494 and the stock's 52-week low/high is $0.842/$20.85.

Recent News

Energy and Water Development Corp. (OTCQB: EAWD)

The QualityStocks Daily Newsletter would like to spotlightFathom Energy and Water Development Corp. (OTCQB: EAWD) .

Energy and Water Development Corp. (OTCQB: EAWD), a leading water and energy solutions provider, has announced the appointment of Bevilacqua PLLC as its new counsel for matters related to the U.S. Securities and Exchange Commission ("SEC") and capital markets, effective April 2024. Bevilacqua PLLC, under the expert leadership of Louis Bevilacqua, will bring a wealth of experience and a proven track record in SEC regulatory and capital markets legal advice to EAWD. The move is part of EAWD's strategic efforts to enhance its legal capabilities and ensure continued excellence in compliance practices. "We are excited to welcome Mr. Louis Bevilacqua and his team at Bevilacqua PLLC as our new SEC counsel," said MSc Irma Velazquez, CEO of Energy and Water Development Corp. "Their deep expertise in SEC regulations and capital markets transactions and their commitment to legal excellence are ideal for guiding our company through the complex landscape of securities compliance."

To view the full press release, visit https://ibn.fm/fsBKd

Energy and Water Development Corp. (OTCQB: EAWD) is a green-tech engineering solutions company focused on delivering water and energy to extreme environments. The company builds water and energy systems out of already existing, proven technologies, utilizing its patent-pending systems configuration and technical know-how to customize solutions to meet clients’ needs. To date, two water systems have been sold and deployed in Mexico and Germany, and the company is working to fulfill additional orders.

Using its patent-pending design, EAWD is working to build and operate off-grid EV charging stations in Germany. The company is a United Nations-accredited vendor and offers design, construction, maintenance and specialty consulting services to private companies, government entities and non-government organizations for the sustainable supply of energy and water.

EAWD focuses on three main aspects of the water and energy business: (1) generation, (2) supply and (3) maintenance. The green tech industry is constantly evolving due to ongoing and increasing water scarcity, as well as increased energy needs in the world. Therefore, the company believes that by designing sustainable and renewable solutions to these problems, EAWD will become an essential component of a rapidly growing industry with many new markets.

EAWD’s approach seeks to assist businesses with the growth and development of their general operations by ensuring the efficient, profitable and sustainable supply and generation of water and energy, allowing its potential customers to focus on their business while adopting strategies of sustainability.

By using the state-of-the-art technological solutions and technologies identified, designed and provided by EAWD and its collaborators, the company believes that its potential clients will be free to focus on the performance of their operations, as well as with the water and energy consumption or generation regulations within their industries.

EAWD is headquartered in Saint Petersburg, Florida, with operations in Germany and Mexico.

Products

In view of the increased worldwide demand for water and energy, EAWD’s business goals are focused on self-sufficient energy-supplied water generation and green energy production. To accomplish this, the company set out to establish an outsourcing green tech platform to commercialize its state-of-the-art technologies while providing engineering and technical consultation services to design the most sustainable technological solutions that can provide water and energy.

The company has sought potential collaboration with green tech research and development centers in Europe and has established its operating subsidiaries in Hamburg, Germany, where EAWD has started to assemble its patent-pending innovative off-grid, self-sufficient energy supply atmosphere water generation (AWG) systems.

EAWD Deutschland and EAWD Logistik operate in Hamburg, Germany, to meet the increasing demands of water and energy generation projects around the world, as well as to operate the solar-powered EAWD Off-Grid EV Charging Stations, EAWD’s newest product.

The company expects to offer sustainable added value to each project it takes on, while generating revenue from the sale of EAWD Off-Grid AWG Systems, EAWD Off-Grid EV Charging Stations, EAWD Off-Grid Power Systems and EAWD Off-Grid Water Purification Systems; royalties from the commercialization of energy and water in certain cases; and licensing of its innovated technologies, along with its engineering, technical consulting and project management services.

EAWD continues to be a development stage company. It presently assembles its EAWD Off-Grid AWG Systems and EAWD Off-Grid EV Charging Stations at its workshop in Germany and outsources most of its engineering and technical services, as well as services relating to the promotion, sale and distribution of its products.

Market Opportunity

According to a report by Allied Market Research, a global market research, consulting and advisory firm, the worldwide green technology and sustainability market was valued at $10.32 billion in 2020 and is projected to reach a value of $74.64 billion by 2030, growing at a CAGR of 21.9% during the forecast period.

A surge in environmental awareness and increasing concerns among organizations and individuals about climate change drive the growth of the market. Furthermore, an increase in consumer and industrial interest for the use of clean energy resources are among some of the major factors expected to boost growth of the market in the coming years, according to the report.

The expected rise in favorable government and private initiatives to tackle climate change and air pollution represent an opportunistic factor of the market. An increase in energy consumption and rise in greenhouse gas emissions are major factors that drive the development of green technology innovations, the report states.

Management Team

Irma Velazquez is CEO and Vice Chair at EAWD. She brings certified expertise in sustainable development and large-scale project management to the company. She formerly worked for United Nations agencies including the World Health Organization, Farmaciens Sans Frontieres, Red Cross and Crescent Societies, where she served in the positions of Information Technology Manager, Sustainable Development Manager, Programme Manager and Disaster and Crisis Management Coordinator. She has a master’s in sciences from the Erasmus University of Rotterdam. She speaks French, English and Spanish.

Ralph Hofmeier is Chief Technology Officer and Chairman at EAWD. He brings a mechanical engineering background to the company and previously served as President of Powermax Energy & Business Solutions Inc. When that company merged with EAWD, he served as President and CEO of Directors of EAWD. Over the last 20 years, he has established and developed several multinational companies in green tech distribution and commercialization. He speaks German and English.

Energy and Water Development Corp. (OTCQB: EAWD), closed Tuesday's trading session at $0.0758, off by 5.25%, on 1,290 volume. The average volume for the last 3 months is 268,424 and the stock's 52-week low/high is $0.0159/$0.12.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower
ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower
ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower
ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

370 N. Hayden Rd.
Suite 123-591
Scottsdale, AZ 85251
480-374-1336

Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.

Copyright © .